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Abstract 
Cancer is one of the leading causes of morbidity and mortality worldwide. One challenge 
is understanding how cancer cells react to heterogenous tumor environments. While there are 
many current practices for researching cancer, microfluidics provides a new approach; therefore, 
the goal of the project was to observe human breast cancer cells within a small, microfluidic 
system. Sharp, predictable oxygen gradients can be modeled and effects such as viability, 
proliferation, and migration of the cells can be observed. The fabricated devices are capable of 
producing an oxygen gradient by flowing nitrogen (0% oxygen) and compressed air (21% 
oxygen) through the PDMS system. Three different gradient lengths were tested, observed, and 
analyzed: sharp (100µm), intermediate (700 µm), and shallow (5mm). Additionally, the cells 
were grown in a hydrogel to better mimic the 3D environment of the body. From the data it was 
concluded that the system with the sharp gradient produced the most migration and proliferation. 
The cells in this device migrated approximately 5.52 +/-5.98 micrometers toward a more 
hyperoxic oxygen level in a 48-hour period. The hyperoxic region of the device saw the most 
migration at approximately 8.5 +/- 7.0 micrometers and the most proliferation as population size 
increased by approximately sixty percent. All three gradients were able to successfully produce 
oxygen gradients. The sharp device was best for observing cell migration and proliferation. 
 
 
Keywords: Microfluidic; oxygen gradient; migration/proliferation 
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1. Introduction 
If you were to ask a room full of people if they knew anyone who has been affected by 
cancer, many, if not all, would raise their hands. About half of all men and about one-third of all 
women in the United States will develop cancer during their lifetimes (American Cancer Society, 
2016). Cancer is the name given to a collection of related diseases and affects many people 
throughout the world. It can start anywhere within the body and is characterized as the abnormal 
growth of cells. These cancer cells grow faster than normal cells and invade surrounding tissue. 
As one of the leading causes of death in the world, cancer accounted for 8.2 million deaths in 
2012 (World Health Organization, 2015). Breast cancer is one of the most common type of 
cancer. In the United States in 2015, there were about 234,190 new breast cancer cases and about 
40,730 deaths (Siegel et al., 2015). Of these cases, about ninety-nine percent were in women and 
one percent were in males.  
Groups all over the world are looking to solve the unknowns of cancer. One challenge is 
understanding how cancer cells react to heterogenous tumor environments. Microfluidics is an 
area of study that has become a method for researching cancer. Microfluidics allows precise 
handling and manipulation of fluids at small volumes, which enables it to be a powerful tool for 
cell analysis (Ning et al, 2016). This technology is very attractive for researchers as the 
microfluidic technique uses less samples and reagents, and shortens time of experiments to 
reduce the overall cost. Cell experiments within a microfluidic device are convenient as 
performance can be predicted through modeling such as finite element analysis, and different 
conditions can be observed simultaneously in the device (Albrecht, 2016). 
Cells behave and function differently depending on the partial pressure of oxygen. A 
normal, normoxic environment in the body is between 2% to 9% (30-90 mmHg). Levels lower 
than these would be considered hypoxic and higher would be hyperoxic. Hypoxic is less than 2% 
oxygen (5 to 15 mmHg) and hyperoxic is greater than normal, such as 21% (greater than 160 
mmHg) (Allen & Bhatia, 2003). Oxygen concentrations are not constant throughout the human 
body. There are gradients throughout all organs, tissues, and vessels; some are gradual gradients, 
while others are sharp (Tsai et al, 2003). Tumors typically have exaggerated oxygen gradients 
because of the high metabolic rate of the cells (Oppegard & Eddington, 2013).  
In order to mimic these regions of low oxygen levels in tumor cells, scientists and 
researchers have created different systems to study cellular behavior in different oxygen levels. 
Current methods include hypoxia chambers and hypoxia workstations, however these only allow 
for static oxygen concentration observation (Brennan et al, 2014). Cancer cell growth has been 
observed within two-dimensional static systems and systems with gradients; however, little 
research has been done in a three-dimensional environment.  
Currently, breast cancer cells have been cultured in different environments within 
different oxygen levels; however, no sharp oxygen gradients have been created even though 
cancer tumors have different oxygen concentrations throughout the tumor. The goal of this 
project is to create a three-dimensional, cost-efficient, reusable microfluidic system that can be 
used to observe cell response to oxygen gradients, particularly cell growth and migration. 
Different oxygen gradients will be studied to detect variation in responses; a shallow, 
intermediate, and sharp gradient will be produced. The information gathered could be used for 
cancer research to develop new drug delivery methods for patients whose tumors are resistant to 
chemotherapy as hypoxia limits drug delivery. By observing cancer cells in different oxygen 
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levels, more can be learned about the cell biology, since it has been shown that gradients of 
oxygen are crucial metabolic regulators. The designed system will more closely mimic the 
microenvironment found at cancer sites.  
The hydrogel microfluidic system was created throughout the year. The first term 
consisted of defining the problem and conducting background research. In the second term, 
materials were gathered, device specifications were created, and conceptual designs were 
developed and evaluated. By testing several small components of the device with finite element 
analysis and physical testing, different designs were developed on the DraftSight program. 
Additionally, oxygen gradients were tested using a fluorescent slide. The third term consisted of 
verification of the oxygen gradients that were modeled and tested as well as more device testing 
and analyzing the results for proliferation and migration through the FIJI image analysis 
program. In the last, final term remaining tests were completed, the report was written, and a 
presentation was given. Different gradients were produced by flowing nitrogen gas (0% oxygen) 
and compressed air (21% oxygen) through a microfluidic device. Different devices were 
produced to create different gradients. These gradients consisted of 0-21% oxygen over a range 
of 100 micrometers, 700 micrometers, and 5 millimeters (sharp, intermediate, and shallow 
gradients). The MDA-MB-231/GFP/Blasticidin, human breast cancer cell line was used to 
observe the growth and migration in the device. PureCol EZ collagen hydrogel was used to 
simulate the 3D environment of the body. To be successful throughout the year, the teammates 
were open-minded, communicated effectively, managed their time well, and were well aware of 
the problem they were investigated.  
The report contains literature review, the project strategy, the design process, followed by 
the final design specifications, verification, validation, and results. Next, the results will be 
discussed, followed by the conclusions, limitations, and recommendations in the final chapter. 
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2. Background 
2.1 Cancer 
Cancer is used to describe a multitude of different diseases that all involve abnormal cell 
growth which can destroy and affect body tissue. The rapid growth of abnormal cells beyond 
their usual boundaries arise from a single cell which becomes a precancerous lesion and then a 
malignant tumor (World Health Organization, 2015). There are over one hundred different types 
of cancer. Some common types of cancer include breast cancer, prostate cancer, melanoma, 
colon cancer, lung cancer, and leukemia (National Cancer Institute, 2016).  
Cancer is one of the leading causes of morbidity and  mortality in the world. In the 
United States it is the second leading cause of death behind heart disease (Siegel, Miller, & 
Jemal, 2015). In 2012, there were fourteen million new cases and over eight million deaths 
worldwide (World Health Organization, 2015). Within the United States, about half of all men 
and a third of all women will develop cancer within their lifetime; there are 1.5 million new 
cancer cases each year and more than 15 million people alive in the United States have had some 
type of cancer (American Cancer Society, 2016). The risk of developing cancer can be reduced 
by changing one’s lifestyle. For example, it is beneficial to not smoke cigarettes, to limit time in 
the sun, to eat healthy, to limit alcohol consumption, to limit exposure to radiation and 
chemicals, to be physically active, and to maintain a healthy weight. The risk of developing 
cancer also increases with age; about 9 out of 10 cancers are diagnosed in people over the age 
50. Cancer can also be passed down in families through genes inherited from previous 
generations (American Cancer Society, 2016). The bottom line is that no one knows the exact 
cause of most cancer cases besides the fact that it can occur when there is a change in the cells of 
the body. Scientists and researchers are studying cancer to learn more about how it forms and 
grows.  
Early diagnosis of cancer is essential in order to try and prevent the disease from 
spreading (World Health Organization, 2015). There are typically three main types of cancer 
treatment: surgery, chemotherapy, and radiation (American Cancer Society, 2016). Surgery is 
usually the first treatment to remove cancer from the body. Chemotherapy and radiation are used 
to shrink the cancer before and/or after the surgery. Chemotherapy is drugs that are used to kill 
cancer cells through the bloodstream. These are taken through IV or by mouth. Some side effects 
include a low blood cell count (which leads to a higher risk of infection), bleeding and bruising, 
anemia, hair loss and nausea. With external (out of the body) or internal (inside tumor) radiation 
therapy, high energy rays are used to kill or shrink the cancer cells. The side effects include skin 
irritation and fatigue. Other types of cancer treatment include targeted therapy, stem cell/bone 
marrow transplants, immunotherapy, and hormone therapy (American Cancer Society, 2016). 
Others use palliative care, which relieves the symptoms, rather than cures the cancer (World 
Health Organization, 2015). While these methods are used to treat cancer, it is surprising that the 
success rate of chemotherapy is only 2.1% over a five-year period (in America) (Morgan et al, 
2004). This means that cytotoxic chemotherapy is a very minor contribution of cancer survival, 
and that the cancer cells are resistant to the chemotherapy treatment. It is imperative to better 
understand cancer cell biology in order to find an alternate solution for treating cancer. 
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2.2 Microfluidics as a new means of researching cancer 
Microfluidics is the precise handling and manipulation of fluids at small volumes, such as 
microliters, nanoliters, or picoliters. This allows for a “small scale benefit (Albrecht, 2016).” The 
minimum unit of a system is addressed as the chambers and channels are controllable, which 
allows for experiments to be reproducible and tunable (Ning et al, 2016). At the microscale, the 
process is faster, less energy is used, and less reagent volumes used; this makes them cheaper 
than alternatives (Albrecht, 2016). Microfluidics has been widely investigated and applied in 
chemical microanalysis, clinical evaluation, environmental monitoring, and biological fields 
(Ning et al., 2016). Within the biological field it can be used in drug discovery, biology, 
diagnostics, and tissue engineering (Riahi et al, 2015). Microfluidic systems can be used to 
create complex drug carriers with precise size and composition; active and localized 
preprogrammed quantities of drugs can be delivered. This can lessen painful and hazardous 
injections (Riahi et al, 2015). 
 Microfluidic chips first emerged in the 1970s (Ning et al., 2016). The materials for 
microfluidics were developed in three stages: the initial glass-and-silicon based inorganic system 
for analyte detection, the polymeric substitution (thermoplastic and thermosetting polymers) for 
cell manipulation and analysis, and the most recent: integrated microfluidics with hydrogel or 
smart biomaterials (Ning et al., 2016). For an example of a microfluidic device, see Figure 1 
below. Currently, microfluidic systems are being used to create complex drug carriers with 
precise size and composition. This may be used for active and localized delivery of cancer drugs 
within the future (Allen & Bhatia, 2003). For example, one study observed how cancer cells 
migrate from an area with little medium, to an area with complete medium. Through this 
research, the cell migration rate was calculated, cell deformation was observed, and ultimately 
provided novel drug targets for metastasis (Zhang & Nagrath, 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
    
Figure 1: “Lab on a chip”- microfluidic device is about the size of a coin. 
 
 Microfluidics is a powerful tool for cell analysis since they can be microanalyzed and 
dynamically monitored, which gives them a “high-throughput benefit.” They also use little 
reagents and have a low detection limit to better observe and analyze cells. Cell experiments are 
convenient and integrated when a single device can have parallel function channels; cells can be 
sorted, cultured, imaged and analyzed within this device (Ning et al., 2016). This allows the user 
to visualize many environments and a large number of cells at once (Albrecht, 2016). Through 
these microfluidic systems, microenvironmental signals can be investigated (Cosson & Lutolf, 
2014). Cellular microenvironments are very important to study since they determine cell 
survival, proliferation, and differentiation (Wan, Wang, & Wang, 2015). Experiments have been 
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used to study cancer cell migration, angiogenesis, and the microenvironment of tumors (Zhang & 
Nagrath, 2013). Additionally, these microdevices are transparent which makes them noninvasive, 
highly sensitive, and able to fluorescently imaged (Ning et al., 2016). Time-lapse microscopy of 
each chamber is possible to thoroughly observe the different conditions. More physiological cell 
culture conditions not found in in-vitro systems can even be created. These include conditions 
such as exchange rate of nutrients or mechanical stimulation (Gomez-Sjoeberg et al., 2007).  
 Lastly, microfluidics have a “quantitative benefit.” This means that the performance of 
the device can be predicted through predictive models such as finite element analysis. By 
creating models, the surface of the microfluidic device can be modified to be more applicable 
and specific. The concentrations and stresses can be measured as well, since the device 
specifications are known (Albrecht, 2016).  
 By using a smart biomaterial or hydrogel there is better biocompatibility, and cell to cell 
communication and cell to surface interaction can be observed. These three-dimensional (3D) 
culture environment better mimics the in vivo environment of the body. It is hard to stimulate 
cell function in vivo in 2D, therefore 2D was limited to in vitro research (Ning et al., 2016). 
 While there are many benefits to microfluidics there are also some disadvantages, 
especially for long term cell culture. For example, these small systems have trouble with medium 
evaporation, limited space for cell growth, and shear stress of the friction of the fluids against the 
cell membranes. It is also difficult to perform routine cell culture such as passaging the cells or 
removing the cells. Hydrogel microfluidics is used to help overcome these challenges . By 
incorporating hydrogel with PDMS, gradients can be generated within 3D scaffolds and cells can 
be shielded from flow and shear stresses (Cosson & Lutolf, 2014). 
 The high sensitivity of microfluidics, high throughput, and enhanced spatio-temporal 
control allow for researchers to control physics, biology, chemistry, and physiology at the 
cellular level. Using microfluidics to address the unmet needs in cancer research can expand 
knowledge of cancer cell biology, management of the disease, and patient care (Zhang & 
Nagrath, 2013). 
2.3 Oxygen Levels and Cell Function 
Cells behave and function differently depending on the partial pressure of oxygen. A low 
oxygen environment is below physiological levels and is known as hypoxic; this is typically less 
than 2% oxygen. A normoxic environment is normal oxygen levels of 2% to 9%. A hyperoxic 
environment is above physiological oxygen conditions. Within the atmosphere the oxygen level 
is 21%; this is a hyperoxic environment to the cells in the body. An environment with no oxygen 
is anoxic (Brennan et al., 2014). In mmHg, hypoxic is 5 to 15 mmHg of oxygen, normoxic is 30 
to 90 mmHg of oxygen, and hyperoxic is greater than 160 mmHg of oxygen (Allen & Bhatia, 
2003). These levels have been considered standard for liver cells in mice and humans, breast 
cancer cells of humans, and colon cancer cells of humans (Allen & Bhatia, 2003) (Lau et al, 
2009) (Fukuda, 2003). 
 Oxygen concentration is not constant throughout the body. In particular, there are steep 
oxygen gradients seen in blood vessels and in cancer tumors (Tsai et al, 2003). Cancer tumors 
are generally hypoxic, especially since cancer cells rapidly outgrow their vasculature. If they 
want to survive, they adapt to these lower oxygen conditions; this creates a poorly perfused 
hypoxic inner region (Brennan et al., 2015). An example of a tumor spheroid and the gradients 
that exist can be seen in Figure 2. As can be seen, the nutrient levels and oxygen levels are much 
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less at the innermost region than the outermost region; this occurs in just 100 micrometers 
(Chandrasekaran & King, 2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Tumor spheroid nutrient, waste, and gas levels (Chandrasekaran & King, 2012) 
 
 It is important to study cancer cells under controlled hypoxic conditions to understand the 
pathophysiology. Research has shown that hypoxia may enhance aggressive phenotypes, tumor 
progression, metastasis, and resistance to therapy (Brennan et al., 2015). Hypoxia and oxygen 
levels are known to alter cancer gene expression by altering transcription of these genes. These 
alterations are under the activity of the transcriptional hypoxia inducible factor (HIF) (Brennan et 
al., 2015). By adapting to hypoxia in cells, the HIF-1 is responsible for transcriptional induction 
of a series of genes that are involved in development, angiogenesis, iron and glucose 
metabolism, cell proliferation, survival, and migration, and apoptosis (Oppegard & Eddington, 
2013). HIF-1 is overexpressed in various cancers and targeting this factor may be a novel 
approach to cancer therapy (Ke & Costa, 2006). 
 In order to mimic these regions of low oxygen levels in tumor cells, scientists and 
researchers have created different systems to study cellular behavior in different oxygen levels. 
Current methods include hypoxia chambers and hypoxia workstations. Hypoxia chambers are 
small enough to fit inside a standard incubator, are inexpensive (about $500), and do not require 
specialized equipment. There is a vessel to place the cell culture plates and dishes. Some 
drawbacks of this chamber are that they are prone to leaks, cannot replicate anoxic (no oxygen) 
conditions, equilibrate slowly, have imprecise levels of oxygen, and are not compatible with 
microscopic analysis. Hypoxic workstations are large, sealed biosafety cabinets that contain the 
gas of interest. There are oxygen sensors and an incubator in the corner of the cabinet. It even 
has a small, gas modulated bench top to perform biological assays. Some drawbacks of the 
workstation includes the cost (over $50,000), and that it cannot be coupled with live cell 
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microscopy (Brennan et al, 2014). Both of these systems only allow for static oxygen conditions 
to be applied and observed. Two-dimensional (2D) and three-dimensional (3D) oxygen gradients 
have been produced, but it is much more common to create them in 2D. For example, one group 
used human lung cancer cells to observe migration toward different oxygen levels in a 2D 
microfluidic system (Figure 3). They found that the cells slightly migrated from an area of 9% 
oxygen, toward an area of 3% oxygen (Chang et al, 2014). 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: 2D migration of human lung cancer cells (Chang et al, 2014) 
 
Another group researched human breast cancer cell viability in a 3D oxygen gradient 
(Figure 4). The gradient went from 0-21% oxygen in an agarose gel either 3mm or 6mm. They 
found that cell viability was not affected in the different concentrations of oxygen (Oppegard & 
Eddington, 2013). Their setup can be seen in Figure 4 below. 
 
  
Figure 4: Setup of agarose gradient system (Oppegard & Eddington, 2013) 
2.4 Breast Cancer 
2.4.1 Breast Cancer Background 
Breast cancer occurs when cells in the breast grow out of control. Breast cancer 
commonly beings in the ducts that carry milk to the nipple. This is known as ductal cancer. In 
some cases it begins in the glands that make the breast milk, which is known as lobular cancer. 
When breast cancer spreads, it spreads through the lymph system which includes the lymph 
nodes, vessels, and fluid (American Cancer Society, 2016). 
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As previously mentioned, breast cancer is one of the most common cancers in the United 
States and in the world (Siegel, Miller, & Jemal, 2015). About one in eight women in the United 
States will develop invasive breast cancer within her life, and approximately 30% of the cancers 
diagnosed in women are breast cancer (U.S. Breast Cancer Statistics, 2017). In 2015 there were 
234,190 new breast cancer cases and 40,730 deaths (Siegel, Miller, & Jemal, 2015). In 2017 
there are an estimated 252,710 new cases expected to be diagnosed in women in the US, and an 
estimated 63,410 new cases. Besides skin cancer, breast cancer is the most commonly diagnosed 
cancer in women. There is an estimate of 2,470 new cases of breast cancer diagnosed in men 
(U.S. Breast Cancer Statistics, 2017). This means that the population that breast cancer affects is 
about 99% women and 1% men (Siegel, Miller, & Jemal, 2015). Additionally, 40,610 women 
from the US are expected to die from breast cancer in 2017; this is the highest cancer death rate 
besides lung cancer. Luckily, the death rate of breast cancer has been decreasing since 1989. This 
decrease is likely due to early screening detection, treatment advances, and more awareness 
(U.S. Breast Cancer Statistics, 2017). 
 The five year survival rate for people with breast cancer is 89%, the ten year survival rate 
is 83%, and the fifteen year survival rate is 78%. The chance of surviving breast cancer depends 
on when the cancer is found (as is true with most cancers). If the breast cancer is found during 
stage 1, which means it is only located in the breast, the five year survival rate is 99%; 61% of 
cases are diagnosed at this point. If it has spread to the lymph nodes, the five year survival rate is 
85% and if it has metastasized and spread throughout the body, the five year survival rate is 26% 
(Cancer.Net, 2016). 
2.4.2 Breast Cancer Cell Line 
There are many different human breast cancer cell lines available for purchase, in fact, 
there are forty-five available from the American Type Culture Collection (ATCC). One of the 
most commonly research human breast cancer lines is the MDA-MB-231/GFP/Blasticidin line. 
These cells are derived from metastatic breast cancer, mammary gland epithelial cells. The GFP 
means “green fluorescent protein,” which means that the cell line expresses the signal-enhanced 
GFP reporter in the genome. While under a blue light of a fluorescent microscope, a strong 
fluorescence is produced (GenTarget Inc., 2016). This is localized in the nucleus and cytoplasm 
to produce fluorescence throughout the cell (Hoffman, 2015). The cell line also has a Blasticidin 
resistance. Blasticidin doesn’t allow for translation to occur in prokaryotic and eukaryotic cells, 
which would ultimately cause cell death (ThermoFisher Scientific).  This is useful to protect the 
cells in hopes that they remain viable and can proliferate.  
 The growing environment for these cells are standard. The media used for culturing is 
composed of Dulbecco’s Modification of Eagle’s Medium 1X (DMEM), 10% Fetal Bovine 
Serum (FBS),  L-Glutamine, and Penn-Strep. In a 50 mL solution, there is 44 mL of DMEM, 5 
mL of FBS, 0.5 mL of L-Glutamine, and 0.5 mL of Penn-Strep. The DMEM is a basal medium 
used to support growth of cells and contains high glucose, amino acids, vitamins,  and phenol 
red. It does not contain any proteins or growth factors (“DMEM, high glucose,” (n.d.)). This is 
why FBS is needed. FBS is a growth supplement for cell culture and has a high concentration of 
embryonic growth factors that promote growth and protect cells from oxidative damage and 
apoptosis (“Fetal Bovine Serum (FBS),” (n.d.)). The L-Glutamine is an essential amino acid that 
supports the growth of the cells, especially those that require a lot of energy by synthesizing 
large amounts of proteins and nucleic acids. It acts as an alternative energy source (“Glutamine 
in Cell Culture,” (n.d.)). The Penicillin-Streptomycin (Penn-Strep) is used to prevent bacterial 
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contamination. The penicillin interferes with the bacterial cell wall and the streptomycin inhibits 
protein synthesis to cause death to the bacteria (“Penicillin-Streptomycin,” (n.d.)). 
 The growing conditions of the cells require a pH of 7.3 or 7.4 (Sokol et al, 2016) and 
normal carbon dioxide levels between 4% to 10%. This level is necessary to keep the pH at the 
appropriate level (“pH & CO2 Levels,” (n.d.)). The temperature is set to 37 degrees Celsius to 
mimic body temperature conditions. The population doubling time is approximately 38 hours at 
these conditions. 
2.5 Microfluidic System 
 Microfluidic systems can be composed of a variety of different components. The system 
used in this experiment consisted of the device, a membrane, a well, slides, hydrogel, cells, 
media, and the gases- nitrogen and compressed air. All of these components have specific 
functions to create the best device.  
A PDMS microfluidic device will be plasma bonded to a glass slide. Additionally, a thin 
PDMS membrane will be plasma bonded to the top of the device. The gas channels that run 
through the device are 100 micrometers deep; the membrane allows for diffusion of the gas to 
occur into the hydrogel (and cells). Plasma bonding activates the PDMS surfaces, which allows 
bonding to occur. This ensures that the device and membrane remain stationary. If the membrane 
were to come off or peel up, the gases within the channels would mix. Also, the membrane keeps 
the hydrogel, media, and cells from going into the channels of the system. On top of the device 
will be a well, which holds the hydrogel, cells, and media. The gases will flow into the system 
through inlets. The device can be seen in the image below (Figure 5). The device (more clearly 
shown by adding a piece of tape on top before plasma bonding to the slide and membrane) is 
approximately 50mm long, 25mm wide, and 9mm tall. It has three horizontal channels that are 
approximately 30 mm long and 5mm wide. There are three inlets where the tubing from the gas 
tanks will be inserted.  
 
 
 
 
 
 
 
 
 
Figure 5: Microfluidic device made of PDMS. There are three channels, three inlets, and one outlet. 
2.5.1 Hydrogel 
Hydrogels are crosslinked polymers that have a hydrophilic group. Water molecules are 
attracted to the negative charges in the crosslink and this creates hydrogen bonding between 
water and the hydrophilic group. Hydrogels have a high water content and some hydrogels are 
able to absorb up to five hundred times its own weight (GSCE, 2015). Additionally, hydrogels 
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have easy mass transportation, better cell viability, and better cell proliferation. They are ideal 
for mimicking the native extracellular matrix of the body (Ning et al, 2016).  
The extracellular matrix (ECM) plays a critical role in the development and maintenance 
of epithelial tissues. The ECM in human breast tissue is a complex mix of protein fibrils that are 
interwoven within a network of glycosaminoglycan carbohydrate chains. The proteins provide 
resistance to tensile forces and the carbohydrates provide resistance to compressive forces. 
Hydrogels are able to more closely mimic this environment (Sokol et al, 2016). Hydrogels are 
used for tissue engineering applications because they have material properties like permeability, 
mechanical strength, and biocompatibility that can be engineered to fit the needs of the 
application. Additionally, the high water content allows them to easily exchange nutrients and 
wastes with the environment (Nuttelman et al, 2001). The highly flexible nature of the hydrogel 
is similar to that of natural tissue (Mellati et al, 2014). It is important for cells to be able to attach 
to the hydrogel as these are strongly influence cell proliferation, migration, differentiation, and 
extracellular matrix production (Nuttelman et al, 2001). Culturing cells within a hydrogel allows 
them to grow in a three-dimensional setting and is most similar to the in vivo environment. Three 
dimensional cell cultures allow for more physiologically relevant modeling ex vivo. All cells, 
even cancer cells, depend on microenvironmental signals for survival, growth, and metastasis 
(Kenny et al, 2007). Gene expression changes can be observed and the morphology of the cells 
can be determined. Breast cancer cells typically have four different morphologies: round, mass, 
grape-like, or stellate. The MDA-MB-231 cells have morphologies of the stellate type, which are 
elongated cell body (Kenny et al, 2007). The different types of morphologies can be seen in 
Figure 6 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6:  Four different breast cancer cell morphologies seen in 3D cultures (Kenny et al, 2007) 
 
There are different substances that can be used as hydrogels; they can be natural or 
synthesized. Some synthetic examples include polyvinyl alcohol (PVA), polylactic acid (PLA), 
and polyethylene glycol (PEG). Natural polymers such as laminin-rich extracellular matrix, 
collagen, cellulose, and more are used as hydrogels (Ning et al, 2016). Additionally, hydrogels 
can be loaded with proteins such as collagen and fibronectin as they are present in human breast 
tissue. Additionally the hydrogel can be loaded with growth factors such as insulin, epidermal 
    11 
growth factors, and hydrocortisone. These help with growth and differentiation of mammary 
cells (Sokol et al, 2016). 3D cultures support the growth of complex tissues and is useful for 
regenerative medicine and for studies tissue development.  
Some limitations of hydrogels include insolubility, uncontrollable pore distribution, low 
mechanical durability, and low microstructure reproducibility (Ning et al, 2016).  
The hydrogel will sit in a PDMS well on top of the device with the cells and media.  
2.5.2 PDMS and Oxygen Diffusion 
Polydimethylsiloxane (PDMS) is commonly used in microfluidics because of its optical 
clarity, biocompatibility, and that is able to be molded down to a submicron resolution (Brennan 
et al, 2014). Additionally, it mimics some natural interactions of stem cells with the 
microenvironment (Cosson & Lutolf, 2014).  
PDMS is highly permeable to gas, particularly oxygen. The diffusivity of oxygen in 
PDMS is 3.25 x 10-9 m2/s (Cox & Dunn, 1986). In water, oxygen has a diffusivity of 1.6 x 10-9 
m2/s at 10 degrees Celsius and a value of 3.33 x 10-9 m2/s at 40 degrees Celsius (Ferrell & 
Himmelblau, 1967). There have been experiments for oxygen control that involve gas diffusion 
through a thin PDMS layer into another area of the device (Brennan et al, 2014). PDMS gas 
permeable membranes have been used in 3D printed microfluidic devices to allow for oxygen 
control in cell culture studies (Brennan et al, 2015). Hydrogels are able to easily be incorporated 
into PDMS structures, and hydrogels can even replace PDMS (Cosson & Lutolf, 2014).  
Some of the disadvantages of using PDMS is that liquid evaporates, protein gets absorbed 
into the media, and non-reacted compounds leach out (Cosson & Lutolf, 2014). 
2.5.3 Gas Flow and Oxygen Sensors 
To produce a hypoxic environment, 0% oxygen will be needed, therefore pure nitrogen 
gas will be used to produce this environment. The atmospheric air is 21% oxygen, therefore a 
tank of compressed air will be used to produce a hyperoxic environment.  
There are several ways to measure oxygen, such as luminescent optical sensors or Clark 
electrodes.  
Luminescent optical oxygen sensors can be ruthenium-based or metalloporphyrin-based. 
These sensors don’t require an electrolyte solution compared to the Clark-type electrodes, they 
don’t consume oxygen in the measurement process (non-invasive), and they can measure oxygen 
in a liquid or gas phase. These sensors have good long term stability and are accurate as they are 
not influenced by the flow rate of the sample. The sensor of the device contains fluorescent dye 
and depending on the amount of oxygen molecules present, the luminescence response varies. 
This luminescent response is then converted into a concentration measurement (Brennan et al, 
2014).  
 On the other hand, clark electrodes require an electrical connection to each position to be 
measured in a single, low spatial measurement. It has an anode and cathode in contact with an 
electrolyte solution. The oxygen tension is measured amperometrically, which means that the 
pressure of the oxygen electrode produces a current at constant polarizing voltage that is 
proportional to the partial pressure of oxygen (Brennan et al, 2014).  
 For a more simplified approach, a fluorescent slide can be used to produce a qualitative 
spatial map. This would not be able to quantify the oxygen levels unless calibrated to the 
microscope and changes in fluorescence. Different levels of oxygen can be observed by blowing 
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gas on the slide. A lower level of oxygen would be brighter than a higher level of oxygen; more 
fluorescence means less oxygen. 
2.5.4 Other Devices 
Aside from the 2D and 3D systems discussed in section 2.3, several other microfluidic 
devices have been created by different groups. One group created a microfluidic hydrogel chip 
and cultured mouse embryonic stem cells on the surface. Through this device they were able to 
spatiotemporally control the delivery of biomolecules through this system (Cosson & Lutolf, 
2014). Another group created a PDMS microfluidic chip where specified conditions in a 96 
culture chambers were full automated. These conditions were customized and included seeding 
density, composition of cell culture, and feeding schedule. Through this system, they were able 
to observe quantitative measurements of the influence of transient stimulation schedules of 
proliferation, differentiation and motility in human mesenchymal stem cells (Gomez-Sjoeberg et 
al, 2007). Another group used a 3D hydrogel scaffold with extracellular proteins and 
carbohydrates to expand primary human breast epithelial cells. After two weeks the cells had 
self-organized to form mature mammary tissue (Sokol et al, 2016). This proved that a 3D 
hydrogel scaffold was able to support the growth of complex tissue.  
2.6 Team Plan 
 There exists a need for a device that can observe cancer cells in a microenvironment 
similar to what is seen in vivo. While groups have created 2D and shallow 3D gradients, not 
much research has been done on observing breast cancer cells in a 3D environment within a 
steep oxygen concentration. The viability, proliferation, and migration of the cells will be 
observed.  
The plan is to create a microfluidic system that uses a hydrogel and creates different 
oxygen gradients (21% to 0% oxygen) in order to represent the two environments: hyperoxic and 
hypoxic. This will be created by flowing nitrogen air (0% oxygen) and compressed air (21% 
oxygen) through the system. A normoxic environment will be created between the channels of 
the device. Three different gradients will be investigated, a shallow 5mm gradient, an 
intermediate 700µm, and a sharp 100µm gradient. These will be generated by changing the 
location of the inlet or by changing the chamber gap widths. A 5mm gradient will be created by 
inserting the nitrogen gas and compressed air into opposite inlets. This means that there will be 
gas flow into the top chamber, then the middle chamber will have no direct gas flow, but will be 
the gradient of 5mm, and there will be gas flow into the bottom chamber. The 700µm and 100µm 
gradients will be created by using different chamber gap width designs (through DraftSight) and 
inserting the gases into adjacent inlets to each other.  
By observing the breast cancer cell line in this environment, cell communication and cell 
migration can be observed. This would not be seen in static oxygen environments. A basic image 
of what will be done is seen in Figure 7. There are three channels, one that is a hyperoxic 
environment, one that is a hypoxic environment, and the gradient between will be determined by 
the distance between these channels (x in Figure 7). Within this region will be a normoxic range. 
On top of the channels will be a membrane, and the hydrogel and cells will sit on top of the 
membrane. 
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Figure 7: Team plan on creating the microfluidic device with a specified gradient  
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3. Project Strategy 
3.1 Initial Client Statement 
 The initial client statement was given to the team by the advisor of the project, Dirk 
Albrecht, before the school year started. It was to “design, characterize, and build a microfluidic 
system that releases a specified oxygen level to the hydrogel-embedded cancer cells.” 
3.2 Design Requirements (Technical) 
3.2.1 Objectives 
 In order to complete the project the following objectives were created: 
1. Design and fabricate a new microfluidic device to create the desired gradient to best 
observe migration and proliferation of cells in a 3D environment. 
2. Quantify and observe gradients of oxygen within the device. 
3. Test viability, proliferation, and migration of cancer cells in three environments 
simultaneously. These environments include the hypoxic (less than 2% oxygen), the 
hyperoxic (21% oxygen), and the gradient (which would include a normoxic region).  
4. Create a cost efficient, reusable device that is useful in a research setting in order to 
further understand cell biology. 
5. Create a versatile device that allows other cell lines to be cultured within it, and can test 
the effects of other gases.  
3.2.2 Functions & Requirements  
 A functional device must be produced that satisfies the objectives. It is required that the 
oxygen diffuses through the membrane of the device and through the hydrogel. This will produce 
appropriate, accurate oxygen gradients, which will be modeled and verified through finite 
element analysis and physical testing. The device must be biocompatible.  
 The three-dimensional environment will be created using a hydrogel. It is important that 
the cells be able to grow and migrate through the gel, and that all required nutrients from the 
media can reach the cells. It is important that the cells remain viable and don’t die though out the 
length of the experiment. 
 There should be no leaking of the contents out of the device. This means that the 
membrane must be properly plasma bonded to the device. The well should fit tightly on the 
device, but it will be removable for easy cleaning. 
 It is important that the gases be flowed at the same speed so that the appropriate gradient 
is produced. Using a microfluidic device will use less energy and lower reagent volumes; it is 
also more reproducible. This means that less gas, cells, media, and hydrogel are used. 
Additionally, the different oxygen environments can be observed at once (hyperoxic, gradient, 
and hypoxic). 
The device must be easily sterilized prior to conducting an experiment, and then after the 
experiment concludes. Sterilization through UV light is effective, easy, and safe. This allows the 
device to be reusable. 
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 The team must keep the cost of materials under the budget of $500; the device and 
materials need to make it must be affordable. The fabrication should be easy for someone new to 
learn. 
 Lastly, it is required that the device be useful in observing cancer cells to see the 
viability, migration, and proliferation. The device must be clear to allow the microscope to focus 
on it and allow for cell observation. 
3.2.3 Specifications 
 The microfluidic device should fit within a standard size petri dish (60mm in diameter) or 
within a larger size petri dish (140mm in diameter). The device will be approximately 50mm x 
25mm x 9mm and the chambers are approximately 30mm x 5mm x 0.1mm. Different gradients 
can be produced in the device by changing the location of the inlets or by creating a new device. 
Since there are three inlets within the device, to create a sharp gradient, the gases would be 
placed next to each other. To create a shallow gradient, these inlets would be placed on opposite 
sides. A new device can be made to increase or decrease the gap width between channels. Figure 
6 is one of the models in DraftSight. 
 In order to seed the appropriate amount of cells into the device, a cell count will be done 
on the passaged cells. Once they are resuspended, a calculation will be done. If 200,000 cells are 
required and there were 1,000,000 cells per mL then: 
1,000,000         =       200,000 
            1,000uL                       X 
 In this case, X would be 200uL.  
3.2.4 Constraints 
 There are some constraints within the project.  New programs must be learned in order to 
predict the gas flow patterns through the device and to design a new one. A finite element 
analysis simulation is essential in order to observe these model gradients in steady state. 
Additionally, the team must learn the DraftSight program in order to design a new microfluidic 
device. Additionally, the team must be comfortable with creating devices using a master, with 
using a fluorescent microscope, and using an image analysis program to analyze the data. 
The team has a budget of $500 dollars to create and test this device. To use the cell 
culturing materials in the lab is a fee of $100 dollars per person. Additionally, supplies such as 
gas tanks, cell lines, tubing, PDMS, connectors, and the master fabrication price must all be 
taken into account. Oxygen sensors, for example, are very expensive. The budget prevents us 
from purchasing one of these precise sensors.   
In order to ensure that experiments are successful, extreme care must be taken. Devices 
must be properly sterilized, cell cultures must remain uncontaminated, wells must be placed 
properly, and the appropriate number of cells and hydrogel must be added. Additionally, the 
images taken to observe the proliferation and migration must be carefully selected and aligned 
each time the device is imaged.  
Lastly, it is important that the hydrogel be completely gelled with the cells before taking 
images, otherwise they can move, especially when media is added. 
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3.3 Standards 
 Standards provide requirements, specifications, guidelines, and characteristics to ensure 
that materials, products, processes and services are fit for their purpose. This means that the 
device must perform, meet safety requirements, show consistency, and be compatible with 
technology.  
 Some standards include: 
• ISO Standards- Requirements , specifications, and guidelines ensure that the product is fit 
for its purpose. 
For CAD/COMSOL: 
o ISO 11442:2006- Basic rules for managing technical documents 
o ISO 16792:2015- Digital product definition data practices 
For sterility: 
o ISO 11737-2:2009- This is the sterilization of medical devices. The device must 
be sterilized in order to successfully grow the cancer cells and ensure no cross 
contamination.  
Petri dish: 
o ISO 24998:2008- Single-use Petri dishes for microbiological procedures 
For safety: 
o ISO 10993-1-Evaluation and testing within a risk management process. Using the 
microfluidic system will be safe for users and pose no potential toxic effects. 
Standardized methodology for cell counting: 
o ISO/WD 20391-1- General guidance for cell counting methods 
o ISO/WD 20391-2- Experimental design and statistical analysis for cell counting 
methods 
Gas flow: 
o ISO 9300:2005- Measurement of gas flow by means of critical flow Venturi 
nozzles 
• IEEE standards- The microfluidic system may incorporate electronic components 
(housed in an incubator) and therefore it must be safe for use and pose no risk of 
electrocution. The device used does not contain any electrical components and the 
incubator standard was not found. 
 
The standards will be incorporated into the design through the materials that are selected 
to be used (hydrogel, oxygen sensor, media, etc). Research will be done to ensure that all 
materials are safe. When the microfluidic design is made, wires, tubing, cells, etc. will be 
observed to make sure that there is no potential for injury to the user. Ethical standards will also 
be incorporated into the design. This will ensure that it is safe for use.  
The device incorporated the following standards:  
• ISO 16792:2015- Digital product definition data practices 
• ISO/WD 20391-1- General guidance for cell counting methods 
• ISO/WD 20391-2- Experimental design and statistical analysis for cell counting methods 
• ISO 24998:2008- Single-use Petri dishes for microbiological procedures 
• ISO 11737-2:2009- Sterility 
• ISO 10993-1-Evaluation and testing within a risk management process 
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The standards that would be recommended before commercialization are: 
• ISO 11442:2006- Basic rules for managing technical documents 
• ISO 9300:2005- Measurement of gas flow by means of critical flow Venturi 
nozzles 
3.4 Revised Client Statement 
 After researching what was currently on the market, and what had been done in more 
detail, a revised client statement was created. 
 
“Since there exists a need for a device that can observe the cancer cells within a steep oxygen 
environment similar to what is seen in vivo, the goal was to create a microfluidic system that 
enables human breast cancer cells (MDA-MB-231) to grow within a three dimensional 
environment by using a hydrogel. Within the system there will be a hyperoxic channel (21% 
oxygen), created by flowing compressed air, and a hypoxic channel (0% oxygen), created by 
flowing nitrogen gas. The area between these channels will be an oxygen gradient. The steepness 
of the gradient will be adjusted depending on the length between the channels. Observing the cell 
viability, proliferation, and migration in these distinct environments and gradients would better 
the understanding of cancer cell biology and how these human breast cancer cells react to 
oxygen microenvironments.” 
3.5 Management Approach 
 In order to accomplish the project objectives, it was necessary to breakdown the work to 
be done. A basic approach chart can be seen in Table 1 below. 
 
Table 1: Rough Work Breakdown by term for the entire year 
 
A-Term B-Term C-Term D-Term 
Research Background 
  
  
Define 
Problem/Objectives/fun
ctions 
 
   
Rough Draft Chapter 1 
and 2  
   
Project Specifications 
  
  
    18 
Conceptual Design 
Development and 
Evaluation 
  
  
DraftSight design 
 
 
 
 
Validation Research 
 
   
Rough Draft Project 
Strategy and Design 
Process 
 
 
  
Testing and Final 
Design 
 
 
 
 
Rough Draft of Design 
Verification and Final 
Design Validation 
  
 
 
Identify area for 
improvement 
  
  
Final MQP Report 
   
 
 As can be seen in Table 1, A-term consisted of a lot of background research, and coming 
up with preliminary designs.  
In B-term, materials were gathered and additional research was done. Preliminary testing 
was done such as verifying that the oxygen gradient could be visualized with a fluorescent slide, 
that the cells could grow within the hydrogel, that migration could be observed, and that the well 
height was high enough to hold the hydrogel, cells, and media. The team also began culturing the 
MDA-MB-231 cells and made different microfluidic devices during this term. Experience was 
gained in cell culturing, device making, and plasma bonding, which proved useful for the future 
work.  
C-term consisted of confirming oxygen gradients in the device through finite element 
analysis and by observing the gradient within the device through the fluorescent slide. It was 
decided that three different gradients would be investigated: shallow, intermediate, and sharp. 
Migration and proliferation experiments were run in both sharp and shallow gradients.  
In D-term, the intermediate gradient was tested and final conclusions were made. A 
presentation was given and the report writing was finalized.  
The team was able to effectively manage their time even with just two team members. All 
tasks were completed on time. 
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4. Design Process 
4.1 Needs Analysis 
Table 2: Analysis of the needs for the device. The table is split up into requirements and how important each 
requirement is (weight). 
Requirement Weight 
Can produce steep oxygen gradient 4 
Can produce 3 different oxygen environments (hypoxic, hyperoxic, gradient (with 
normoxic))  
5 
Hydrogel is oxygen permeable 5 
Hydrogel allows for successful cell culture (3D environment) 5 
Hydrogel contains additional growth factors 3 
Can further knowledge on cell biology of cultures 3  
Cells grown in a temperature of 37 degrees Celsius 5 
Low cost (Less than $500 budget) 2 
Reusable 2 
Able to culture other cell lines 2 
Able to test the effects of different gases 1 
 
We rated our requirements by their importance in order to achieve our goal. They are weighted 
from 1 (not necessary) to 5 (must have).  
 
5 (Must Have) 
The final product must have three different oxygen environments (hypoxic, hyperoxic, 
and a gradient). The gradient will be changed based on how wide the chamber widths are. 
Diffusion of oxygen through the membrane will be diffused into the  hydrogel that is permeable 
by oxygen. The hydrogel should also be able to successfully culture cells in a 37°C environment; 
it can vary since some hydrogels are specific for certain cell lines. 
4 (Important) 
The second goal is to provide a microfluidic system that can produce a steep oxygen 
gradient. The term “steep gradient” is subjective. Research articles have produced gradients of 
3mm or 6mm in 3D, but none have been found smaller than this. The steep gradient would be 
100 micrometers. This is much smaller than the previous research done and more applicable to 
what can be seen in vivo.  
3 (Good to Have) 
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By creating this device, it will be useful in a research setting and hopefully further the 
knowledge on cell biology of cultures. The hydrogel that is selected for use within the system 
could be injected with additional growth factors to further the growth of the cells. 
2 (Not Needed, but Would Be Nice to Have) 
An additional goal is to provide a low cost and reusable device can be used to culture any 
cell line and provide more research on how oxygen levels affect the chosen cell line. As far as 
the cost goes, oxygen sensors are expensive and alone would be over the budget. Regardless, 
they are important for this system and necessary in order to ensure accurate oxygen 
environments.  
1 (Not Necessary) 
The last goal is to test the effects of different gases on cell lines. Since oxygen is already 
being used, the supply to a different gas can easily be changed, but it is not a priority.  
 
 Currently there has been little research done on observing cell growth within a steep 
oxygen gradient hydrogel microfluidic system. Cancer cell growth has been observed within 
different oxygen concentrations, particularly in a static or 2D setting. By observing the cells over 
steep gradients, cell response to different environments can be observed. The cells may migrate; 
this wouldn’t be seen in a static system. Additionally, proliferation and viability within the 
different environments can be simultaneously be observed. 
4.2 Concept Map & Conceptual Designs 
The basic concept map in the figure below shows the fundamentals of the device. This 
device will have an oxygen gas gradient that ranges from steep to shallow. Within this device 
cancer cells will be cultured in a three-dimensional environment. 
 
Figure 8: Basic Concept Map 
 
 A more advanced concept map can be seen below (Figure 9).  
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Figure 9: Advanced Concept Map 
 
The concept map above includes several important design attributes. Within the system, 
the MDA-MB-231/GFP/Blasticidin, human breast cancer cell line will be grown. The cell media 
used will be DMEM/10% FBS/2 mM L-glutamine1X PennStrep and the cells need to grow in a 
temperature of 37 degrees Celsius. There are several hydrogel options as can be seen above. 
Some options include laminin-rich ECM, ECM with growth factors and proteins, a PEG/PDMS 
gel, polyvinyl alcohol with fibronectin, or collagen. Laminin rich and loaded ECM hydrogels 
best resemble natural in vivo since they contain natural growth factors and proteins. These help 
with growth and differentiation. PEG/PDMS can be molded down to the sub-micron resolution 
and is optically clear. Polyvinyl alcohol is an option but fibronectin is needed to promote cell 
adhesion. Lastly, using collagen is a more natural approach. PureCol EZ can be used to provide a 
firm gel or in a thin layer. The system also has to be able to create three different oxygen 
environments (hypoxic, normoxic, and hyperoxic), by flowing nitrogen gas and compressed air. 
There are different ways of delivering the oxygen and media. Syringe pumps are an easy way to 
deliver media; the pump is set to the rate at which to expel the media from a syringe so the flow 
rate is directly controlled. Other methods would use a difference in pressure such as hydrostatic 
pressure or pressurized reservoirs. These are easy to regulate but the flow rate can change.  
Passive pumping is easy, but it is sensitive to evaporation and flow rates are variable. The 
oxygen will be delivered by the gas tanks. The design of the device will include channels that are 
more than 50 micrometers wide, and more than 100 micrometers apart. The inlets will be circles 
approximately 1 millimeter in diameter.  Additionally, there needs to be space around the edges 
and ports, so that they are not too close to the edge; this minimizes diffusion out of the device. 
Oxygen can be measured quantitatively with clark style electrodes or luminescent optical 
sensors. Oxygen can be distributed through individual inlets, by diffusion, or by both. 
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4.3 Alternative Designs 
4.3.1 Alternative Design #1 
One alternative design was given to the team at the beginning of the project. There are 
three different compartments for each of the different oxygen environments. There would be at 
least three inputs and three outputs, each containing a different oxygen level (Figure 10). There 
is a thin PDMS membrane that separates the channels from the extracellular matrix hydrogel and 
cells. This would allow for diffusion of the gases to occur into the hydrogel. The device is made 
of PDMS.  
 
 
Figure 10: Alternative Design 
4.3.2 Individual Tests for Final Design 
Different individual tests were done which led the team to create the best design.  
4.3.2.1 Well Test & Media Replenishing 
 Three different well heights were made using SYLGARD 184 Silicone Elastomer Kit. 
One well had a height of 5.6mm which was made of 20g of PDMS, the next well had a height of 
7.4mm which was made of 30g of PDMS and the final well had a height of 12.3mm which was 
made of 70g of PDMS. To test the wells, each well was placed on top of the microfluidic device 
and 1mL of water was added in increments until the well either leaked or spilled. This amount 
was chosen because the hydrogel, cells, and media within the well equated to approximately 
2mLs of liquid. If the well could hold more than this amount without leaking, it proved that the 
well was capable of holding the components needed for each experiment. 
 Result: From this well test, it was concluded that 12.3mm height well would be ideal for 
our final design because it was able to hold the necessary volume for each experiment. The 
smaller well heights couldn’t properly hold all components and anything larger would affect the 
petri dish covering.  
 
 The team discussed replenishing the complete media within the 12.3mm well in case of 
media evaporation or the capillary effect. The capillary effect was common in wells lower in 
height; the large amount of liquid within the well tended to touch the top glass cover slide. This 
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caused the liquid to be drawn up and out of the device. A syringe pump was used and set to 
different speeds like 0.25mL/hr and 0.1mL/hr. A syringe pump filled with 10% FBS complete 
media was attached to tubing that went into the incubator. A special inlet was made within the 
well to provide a stable access point for the media to drip onto the hydrogel 
 Result: From tests using the syringe pump it was determined that a syringe pump was not 
needed because evaporation was not occurring that fast. It was much easier to replenish the 
media by hand if necessary. Usually it was not necessary as one to two milliliters of media was 
plenty for 200,000 cells for 48 hours. Additionally, with the higher well height, the capillary 
effect did not cause any media to be drawn up and out of the device.  
4.3.2.2 Hydrogel Experiments 
 Preliminary testing of hydrogel began with PureCol EZ bovine collagen. The purpose of 
the experiments was to observe cell proliferation and migration in the hydrogel. Images were 
taken at 0 hours, 24 hours, 48 hours, and 72 hours using the ZEN Program with the Zeiss 
Axiovert 40 CFL Fluorescent microscope. Using FIJI, images were compared at each time point 
to observe cell proliferation and migration. 
 Results: 
Experiment #1: After 24 hours, cell growth was observed on the hydrogel. After 48 hours, a 
sterile scalpel was used to add a scratch to the hydrogel to observe migration across the scratch. 
A pipette tip would not be able to cut the hydrogel due to its jello-like substance. A cross was 
drawn on the bottom of the petri dish to be used as a reference point when taking the images 
under the microscope. 2mL of fresh media was added after aspirating the two-day-old media 
from the hydrogel well. After 72 hours, contamination was observed. A cloudy substance had 
formed on top of the hydrogel preventing clear images of the cells seeded within the hydrogel. 
The assumption was made that the contamination came from the scalpel cute done the day before 
and the experiment ended at this time. 
Experiment #2: The same area of the hydrogel was observed at each time point when taking 
images. After comparing the 0 hours, 24 hours, 48 hours and 72 hours it was concluded that there 
was proliferation in the hydrogel (Figures 11 & 12), and therefore justified the choice for using 
PureCol EZ as the hydrogel. The Figures get brighter and more cells are seen after each 24 
hours, which indicates an increase in proliferation. A scratch test was done in the middle of the 
hydrogel. Upon observing particular cells, it was seen that the scratch had cells within it, 
therefore proving that there was migration. 
 
Figure 11: Cells after 48 hours with fluorescence (20X magnification) for experiment 2 
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Figure 12: Cells after 72 hours (left) compared to after 96 hours (right) for experiment 2 
4.3.2.3 Hydrogel Amount Test 
Another hydrogel experiment was done in a 24 well plate to determine the necessary 
amount of PureCol EZ to use for cell proliferation and migration in our final design. The 
amounts tested were 250µl, 500µl, and 1mL. 
 Images were taken at 0 hours, 24 hours and 48 hours using the ZEN program with the 
Zeiss Axiovert 40 CFL Fluorescent microscope. Using FIJI images were compared at each time 
point to observe cell proliferation and migration.  
Result: There was cell proliferation and migration in all three well amounts. At 0 hours, 
all cells were between the hydrogel and by 48 hours the cells had migrated closer to the bottom 
of the well. This could be caused by the fact that the bottom of the wells are treated for cell 
culturing. 
 
The team experimented with adding 250µl, 500µl, 750µl, and 1mL of PureCol EZ 
hydrogel to the device.  
Result: 1mL of hydrogel was chosen. A hydrogel amount of 250µl or 500µL tended to 
peel up when the gases began to flow since it was so thin. An amount of 1mL was perfect as it 
remained stationary and all layers could be seen in the device. This ensured that all cells were 
seen. An image the 1mL hydrogel without the well can be seen in Figure 13. Additionally, 
Figure 14 shows a hydrogel that peeled up because it was too thin.  
 
 
Figure 13: Successful 1mL hydrogel on device with no well 
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Figure 14: Thin hydrogel that peeled up and folded over (seen near top of well) 
4.3.2.4 Cells to Seed 
The MDA-MB-231 cell line was chosen because it is a commonly researched human 
breast cancer cell line and it expresses the GFP reporter, which will allow migration and 
proliferation to be easily observed under the microscope. For information on cell passaging, and 
the number of cells that were passaged, see Appendix A. 
Experiments were conducted to determine the proper amount of cells to seed into the 
hydrogel to allow proliferation and migration in our final design. Experiments were seeded with 
2.5 million cells, 2 million cells, 1 million cells, or 200,000 cells. 
Results: From the experiments, it was concluded that 200,000 cells was the ideal number 
of cells to seed because it allowed more space to observe proliferation and migration compared 
to the larger number of cells seeded. Having too many cells was difficult to observe migration 
since not a lot of empty space was available to clearly see the migration of cells. 
4.3.2.5 COMSOL Simulations 
 COMSOL is a finite element analysis program.  The entire device was simulated and 
modeled in 2D in COMSOL, however, only the hydrogel, membrane, and chambers are depicted 
in the following simulations, as these are the components that affected the gradient. The 
following parameters were used to create the model: 
 
• Hydrogel Dimensions: 27mm x 1.7mm(Thickness) 
• Membrane Dimensions: 25mm x 0.063mm(Thickness) 
• No flux boundary all around the system 
• Diffusivity of Oxygen in PDMS: 3.25*10-9[m2/s] 
• Diffusivity of Oxygen in Water: 1.97 x 10-9 [m2/s] (Ferrell & Himmelblau, 1967) 
o Simulates diffusion of oxygen in the hydrogel 
• 3 Chambers: 5mm x 0.1mm each 
• 100um gap between each chamber  
• 21% oxygen in one chamber 
• 0% oxygen in one chamber 
 
The entire device was modeled in COMSOL and meshed; however, for clarity purposes only 
the chambers, hydrogel, and membrane are represented in the section, since adding the bottom of 
the device did not affect the slope of the gradient. The boundaries were considered no flux 
because of the large width between the edges, particularly the area from the chambers to the 
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bottom of the device, and the chambers to the sides of the device. A complete image of the 
device model can be seen in Appendix C.  
Using COMSOL three different oxygen gradients were modeled of the three different 
designs. The shallow gradient (5mm gap) had a broader oxygen gradient compared to the 
intermediate gradient (700µm) and sharp gradient (100µm). These can be seen in the Figure 
below. For the oxygen gradient models, the parameters stayed the same. The shallow gradient 
has the 21% oxygen and 0% oxygen inlets on opposite sides creating a 5mm oxygen gradient in 
the model. In the intermediate gradient, the gap between each chamber was changed from 100µm 
to 700µm to and the 21% oxygen and 0% oxygen inlets were next to each other to produce the 
oxygen gradient shown in the model. For the sharp gradient, the 21% oxygen and 0% oxygen 
inlets were next to each other over a 100µm gap to produce the oxygen gradient shown in the 
model. The maximum slope of the oxygen gradient for the shallow gap is 0.31 O2%/100µm (over 
approximately 6mm of the gradient) (3.1 O2%/mm), the maximum slope for the intermediate 
gradient is 1.4 O2%/100µm (in 700µm of gradient) (14% O2%/mm), and the maximum slope for 
the sharp gradient is 2.5 O2%/100µm (over approximately 200µm of the gradient) (25 O2%/mm). 
 
Figure 15: COMSOL Model Comparing Oxygen Gradients 
 
 COMSOL was used to simulate other important factors. 
Thickness of Membrane: The thickness of the PDMS membrane is an important factor for our 
experiment (Figure 16). If the membrane is thick it would take longer for the gases to diffuse 
through and reach the seeded cells. A 63.5µm, 250µm, 500µm and a 1mm thick membrane were 
compared and are shown in the figure below. For the membrane thickness modeling, the 
parameters stayed the same except the membrane thickness was changed to 63.5µm 250µm, 
500µm, and 1mm. The difference in gradient can be seen when comparing the average oxygen 
gradient of the 63.5µm membrane to the 1mm membrane. The maximum slope of the oxygen 
gradient for the 63.5µm membrane is 25.00 O2%/mm. The maximum slope of the oxygen 
gradient for the 250µm, 500,µm, and 1mm were taken by looking at the steepest part of the 
average slope. This created lower values than what would be seen if it was zoomed in, because it 
is a sharp gradient. The average maximum slope of the 250µm membrane is 3.33 O2%/mm. The 
average maximum slope of the oxygen gradient of a 250µm membrane is 7.00 O2%/mm and the 
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average maximum slop of the oxygen gradient of a 500µm membrane is 4.8 O2%/mm. It was 
decided to use a 63.5µm thick membrane because the oxygen gradient was the sharpest 
compared to the oxygen gradients in the other models; a thicker membrane has a broader 
gradient. 
 
Figure 16: COMSOL Model Comparing Membrane thickness 
 
Slide Covering: Another important factor was whether to use a slide cover or not (Figure 17)-. 
For the device covering model, the parameters stayed the same except that a 21% oxygen 
concentration was allowed on the top boundary (open top). For the closed top, the top boundary 
was set to no flux, preventing 21% oxygen to enter the system (oxygen gradient). From the open 
top model, it can be observed that there is a much smaller oxygen gradient visible because the 
oxygen coming from the top interferes with the gradient within the hydrogel. The atmospheric 
air affects a lot of the hydrogel and there is a sharp gradient that moves vertically throughout the 
gel. The team wanted to observe the cell affects of an oxygen gradient across a horizontal 
gradient. The vertical gradient that the open top produced could not have been observed under 
the inverted microscope. In the closed top model, which did not allow oxygen through the top, it 
can be observed that the oxygen gradient stays consistent throughout the device. The maximum 
slope of the oxygen gradient of the closed lid is 3.38 O2%/mm and the maximum slope of the 
oxygen gradient of the open lid is 6.5 O2%/mm. From the COMSOL model it was concluded that 
having a slide cover would keep the oxygen gradient consistent throughout the entire device and 
the experiment duration. If the well was left open, the atmospheric oxygen would interfere with 
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the experiment thus affecting the results. For this reason the team decided to use a slide cover to 
maintain a consistent oxygen gradient as shown in the closed top model. 
 
Figure 17: COMSOL Model of Device Covering 
  
 There were several other COMSOL simulations done. One of them was investigating the 
hydrogel height. This had a minimal effect on the gradient. For the hydrogel height model, the 
parameters stayed the same except the hydrogel height was changed to 0.5mm, 1mm, 2mm and 
3mm. As can be seen in the models below (Figure 18), the oxygen gradient stays consistent 
through each model. The max slope of the oxygen gradient of a 0.5mm hydrogel height is 3.5 
O2%/mm, the max slope of the oxygen gradient of a 1mm hydrogel height is 3.25 O2%/mm, the 
max slope of the oxygen gradient of a 2mm hydrogel height is 3.0 O2%/mm and the max slope of 
the oxygen gradient of a 3mm hydrogel height is 2.75 O2%/mm. Concluding that the hydrogel 
height does not affect the oxygen gradient. This concludes that the hydrogel height does not 
affect the oxygen gradient. Additional less important factors can be seen in Appendix C, along 
with the graphs of the oxygen concentration throughout the device. These include the width of 
the chambers (3mm or 5mm), and a two-chamber device as opposed to a three-chamber device. 
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Figure 18: COMSOL Model Comparing Hydrogel Height 
4.4 Final Design Selections 
	   The team has decided to use a 47mm X 28mm X 5mm (~50mm x 25mm x 5mm) device 
made from the silicone master provided. The device is made out of polydimethylsiloxane 
(PDMS) and it is plasma bonded to a glass slide. Within the device are 1mm holes punched from 
the top and side. There are three inlets and one outlet hole punched. Only two inlets will be used; 
one will flow nitrogen gas (0% oxygen) in order to produce a hypoxic environment and the other 
will flow compressed air (21% oxygen) to produce a hyperoxic environment.  
There is 63.5µm thick PDMS membrane plasma bonded to the top of the device that 
covers the top holes and system since only the side holes will be used to flow the gases as 
discussed in 4.3.2.5. This membrane will allow for the gases to diffuse through and produce the 
appropriate oxygen conditions. On top of the membrane will be a well with a height of 12.3mm 
made from 70g of silicone base and 7g of silicon curing agent in a white weigh boat, as the well 
is sturdy and able to contain the necessary volume of cells, hydrogel, and media without leaking 
or spilling as discussed in 4.3.2.1. The well will be thoroughly cleaned with ethanol and 
kimwipes before it is placed on the device. This component will not be plasma bonded to the 
device to make the device reusable and easier to clean. To see the cleaning protocol go to 
Appendix B. PDMS naturally adheres and creates a seal with clean PDMS. The user will be able 
to easily remove the well after the experiment is complete and clean the components 
individually.  
Within the well, there will be MDA-MB-231/GFP/Blasticidin human breast cancer cells 
seeded in PureCol EZ and media for cell growth. There will be approximately 200,000 cells 
(75µL-85µL) seeded in 1mL of PureCol EZ and 1mL of complete media for each experiment as 
discussed in 4.3.2.1, 4.3.2.2, 4.3.2.3, and 4.3.2.4. A slide cover will be placed on top of the well 
to prevent any atmospheric air from interfering with the experiment, providing an airtight seal. 
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The device will be housed within a large petri dish (140mm x 20mm). The petri dish will be 
contained within an incubator set at 37°C, to allow proper growth conditions of the breast cancer 
cells. The tubing will be placed in the incubator in such a way that it does not affect the seal of 
the incubator to ensure that no heat or carbon dioxide is wasted. Gases will flow into the inlets 
through a 6.35mm tubing that is attached to a compressed air tank and a nitrogen gas tank. The 
pressure of the tanks will be kept at 14 kPa (2psi), which is sufficient to produce the gradient, but 
also ensure that the membrane isn’t stressed. Too much flow will cause evaporation. The tubing 
at each tank is secured by a zip tie. At the end of the tubing, a syringe tip is secured to the tubing 
by a luer adapter. The syringe tip is attached to a smaller diameter tubing (0.85mm), which fits 
inside a pin that is placed within the inlets of the device. This allows a tight fit to ensure that 
there is no leakage while the experiment is running.  
An image of the breast cancer cells in the device will be taken each day after they are 
seeded into PureCol EZ to observe migration and proliferation. In particular, reference points 
will be chosen on the device to clearly see any migration or proliferation (Figure 19). The team 
expects to observe cell migration to a certain oxygen environment, particularly the hyperoxic 
region since the most oxygen is within that area. This area may also have the most proliferation. 
The length of each experiment will be 48 hours. The final setup can be seen in Figure 20. The 
estimated prices of all the needed materials are in Appendix D. Additionally, the Standard 
Operating Procedure for setting up and running the experiment can be found in Appendix E. 
 
Figure 19: Example of a reference point used to observe cell proliferation and migration. 
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Figure 20: Final setup of device in incubator 
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5. Design Verification 
 The tests done in Chapter 4 allowed for a final design to be selected. This chapter 
presents the core project findings for the oxygen gradients produced and for the viability, 
proliferation, and migration of the human breast cancer cells within the three different oxygen 
gradients (5mm, 700µm, and 100µm).  
5.1 Oxygen Gradient Confirmation  
A qualitative spatial map was used to visualize oxygen levels. By using the ZEN program 
with the Zeiss Axiovert 40 CFL Fluorescent microscope, gas flow was observed on a fluorescent 
slide and within the device. The brightfield phase was used and the light from the microscope 
was closed to only observe fluorescence. Additionally, instead of using auto-exposure, it was set 
to 100. The FIJI program was used for the image calculations. These images were unmodified 
and were saved as ome.tiff. This made sure that there were no pixel modifications or adjustments 
by the program.  
5.1.1 Oxygen Gradient Confirmation on Florescent Slide 
Carbon dioxide gas (0% oxygen) was blown onto an OceanOptics Ruthenium-Coated 
fluorescent slide  (part name FOXY-SGS-M, price $275.00) under green light. Figure 21 shows a 
visual on how the syringe tip was attached to the tubing and blown onto the slide under the 
microscope. The syringe tip was taped down to ensure that no movement occurred. 
 
Figure 21: Conceptual image of carbon dioxide being blown onto fluorescent slide 
 
The slide before the gas was turned on and during the gas flow can be seen in Figures 22 
and 23. 
        
Figure 22: Before carbon dioxide flow on slide (left)/ Figure 23: During carbon dioxide flow on slide (right) 
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 The images are rather dark. Using FIJI, the location during the time when the gas was 
flowing was divided by the location when the gas was turned off; the image with carbon dioxide 
flow was divided by the initial image (atmospheric air hitting the slide, approximately 21% 
oxygen). The result was showed as a 32-bit (float) result. The images can be seen in Figure 24. 
The black and white image was what was originally outputted since the images themselves were 
in black and white. To add more contrast, the look-up table (LUT) ‘Fire’ was added (Figure 24). 
The flow of gas can clearly be distinguished. A value of one meant there was no change; this is 
equivalent to atmospheric air (21%). A value greater than one meant that the image got brighter. 
The more saturated regions had a value of approximately two; there was a large amount of 
change here and meant that the oxygen content was approximately 0%. The lower left-hand 
corner had a value of approximately 1.4, so while it doesn't look especially bright (especially 
when comparing to the brightness around the tip) it still changed. This method allows the team to 
qualitatively visualize spatial oxygen levels at the micron-scale, which makes it suitable to 
measure the sharpest gradient the team intends to make (100µm).  
 
  2.0 (0%)  1.0 (21%) 
Figure 24: Black and white result of division (left). LUT Fire result of division (right). 
 
 Figure 24 also shows a tracing of the needle to help visualize the flow of gas. The 
brighter, more yellow region has a low level of oxygen. The purple region behind the needle 
represents the atmospheric air hitting the slide. This test confirmed that the slide could 
effectively show oxygen change. 
5.1.2 Oxygen Gradient Confirmation Within the Devices 
Since it was confirmed that oxygen gradients could be visualized with the fluorescent 
slide, it was used to observe gradients within the device. Nitrogen was flowed into one inlet, and 
compressed air was flowed into the adjacent inlet. The chamber gap between both of these 
regions was focused on under the microscope. Both gases were flowed at the same rate. The 
device was placed upside down on the fluorescent slide so that the membrane was in contact with 
the slide. This can be seen in Figure 25. The pins and tubing were stabilized to ensure that no 
movement of the pins, tubing, or slide occurred, as this would produce inaccurate results.  
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Figure 25: Device on fluorescent slide under fluorescent microscope 
 
Black and white images were produced; images were taken before the gases were turned 
on and when the gases were flowing. FIJI was used to create the division images and the LUT 
‘Fire’ was added.  The images produced were similar to what was expected.  
 
 
 
 
1 (21%)  1.75 (0%)   1 (21%)  2 (0%) 
Figure 26: Oxygen gradients in sharp and intermediate gap devices 
 
As can be seen in Figure 26, there is a visible difference between the hypoxic region (low 
oxygen) and the hyperoxic region (high oxygen). The low oxygen is again visualized by a 
brighter color (yellow), while the high oxygen is visualized by a darker color (purple). 
 The sharp 100µm gradient can be visualized between the two chambers. The plot below 
is to scale; it shows the oxygen percentage from 0-21% along the field of view. The field of view 
is 2mm in width, and therefore so is the plot. The slope of the sharp gradient plot is steep, which 
corresponds to the sharp color change within the chamber gap of the device. The scale for 21% 
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oxygen would be a dark pink, since that is what is seen within the hyperoxic chamber. The range 
goes from 1, which is approximately 21% oxygen, to approximately 1.75, which is 0% oxygen.  
 The intermediate 700µm gradient can be visualized more easily than the sharp gradient. 
The slope of the plot is less steep than what is seen in the 100µm. The gradient change within the 
gap can be seen and corresponds to the plot. It goes from a bright yellow on the hypoxic chamber 
side (value of 2), to a dark purple in the hyperoxic chamber (value of 1). 
 The maximum slope of the oxygen gradient for the sharp gradient is 5.75 O2%/100µm (over 
approximately 200µm of the gradient) (57.5 O2%/mm (in the gradient)), the maximum slope for 
the intermediate gradient is 1.85 O2%/100µm (in 700µm of gradient) (18.5 O2%/mm (in the 
gradient)), and the maximum slope for the shallow gap is 0.31 O2%/100µm (over approximately 
6mm of the gradient) (3.1% O2%/mm). There is a large difference in gradients. The oxygen 
gradient with the units O2%/mm was done if the gradient was extrapolated to a millimeter. 
 
Oxygen Gradient 200µm Above the Membrane 
 
 These tests confirmed that an oxygen gradient can be visualized on the membrane of the 
device. Since the cells will not sit directly on the membrane as they will be within the hydrogel, 
plots were made to visualize the gradients at this elevated area above the membrane. This was 
simulated at 200µm from the membrane. These can be seen in Figure 27. The location of the 
cells above the membrane can be seen in the COMSOL Figure below (Figure 28).  
 
 
 
Figure 27: Oxygen gradients within the hydrogel where the cells are seeded 
 
   21% O2   0% O2 
Figure 28: COMSOL model of cells in gel. The red axes show 200 micrometers above the membrane to simulate 
where the cells are in the hydrogel (1.97 x 10-9 m2/s oxygen diffusivity in hydrogel, and 3.25 x 10-9 m2/s oxygen 
diffusivity in PDMS) 
 As can be seen in the Figures, the oxygen gradient was not as drastic for each of the gaps 
widths as was seen in Figure 26, but there is still an obvious difference in slopes. By observing 
the figures, the max slope for the sharp gradient is approximately 2.5 O2%/100µm (25 O2%/mm 
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in the gradient). The intermediate gradient has a slope of about 1.4% O2%/100µm (14 O2%/mm 
in the gradient). There is quite a difference in the sharp gradient at the membrane compared to 
200µm above the membrane. This is why the cells were seeded as close to the bottom as 
possible. 
 It must be noted that there is no visual gradient for the 5mm shallow gradient. This is 
because the 5mm gradient could not be visualized under the 5X lens of the microscope. It must 
be assumed that the COMSOL models were correct, especially since they were correct for the 
sharp and intermediate gradients, and that the gradient was in fact produced.  
5.2 Proliferation & Viability 
To observe the proliferation and viability FIJI was used. A fluorescent image focused on 
the cells at the specific reference point was taken. These images were saved as ome-tiffs; they 
were 16-bit images. Using FIJI, the background was subtracted by adjusting the threshold. The 
threshold was adjusted so that only the cells were visible. This was a value of approximately 
5,000-7,000, depending on the original brightness of the image. The bottom condition was turned 
up to 100 percent threshold so that the entire image was red (a value of 65,520). The top 
condition was then lowered until only the cells were visible. Only about 5-10% of the image was 
visible then. This depended on how many cells were visible within the screen. The cells in 
clumps were separated through the watershed process. Then the cells were counted through the 
‘analyze particles’ analysis tool. The defaults were kept to view the results. The size was kept 
from 0-infinity, the circularity went from 0-1, and clear results and summarize were checked 
within the window. The cell number was then displayed under ‘count.’ Other components such 
as average size, and percent area were displayed. A before image and after image analysis can be 
seen in Figure 29.  
 
Figure 29: Fluorescent image of cells before FIJI analysis (left) and after (right) 
 
 A cell count was done for each experiment at each timepoint (0, 24, and 48 hours). These 
were each compared and added to a table. Originally the entire proliferation was compared to the 
next entire image at each timepoint, but to make it more specific the analyzed image was broken 
into the appropriate regions. The original reference image for each timepoint was used to observe 
where the particular regions were. This allowed for an accurate cell count of the hyperoxic, 
hypoxic, and gradient region.  
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 The data for the sharp experiments can be seen in Tables 3 and 4. The cell counts for 
each environment (hyperoxic, gradient, and hypoxic) can be seen. The percentage increase was 
found by taking the cell count at the time point, subtracting the initial cell count, and dividing by 
the initial cell count. The answer would be multiplied to find the percentage. For example: 
 
%Increase = ((24 hour count) - ((0 hour count))/(0 hour count)) x 100 
%Increase = ((529-253)/253) = 109.1% 
 
Table 3: Sharp Experiment #1 Cell Proliferation 
Time 
0 
hours 
24 
hours 
48 
hours 
% Increase After 24 
hours 
% Increase After 48 
hours 
Hyperoxic 253 529 676 109% 167% 
Gradient 49 57 58 16.3% 18.4% 
Hypoxic 151 151 134 0.00% -12.7% 
Total 
Cells 453 737 868 
   
Table 4: Sharp Experiment #2 Cell Proliferation 
Time 
0 
hours 
24 
hours 
48 
hours 
% Increase After 24 
hours  
% Increase After 48 
hours 
Hyperoxic 569 602 678 5.80% 19.2% 
Gradient 158 168 179 6.33% 13.3% 
Hypoxic 189 204 212 7.94% 12.2% 
Total 916 974 1,069 
   
To find the averages percentages (seen in Table 5), each cell count in the environment at 
both experiments was averaged first, and then the percentage increases were found. The standard 
deviations of the two sharp experiments were calculated as well. 
 
Table 5: Sharp Experiment Average Proliferation 
 
0 
hours 
24 
hours 
48 
hours 
% Increase After 
24 hours  
St.Dev. % Increase 
After 48 hours 
St.Dev. 
Hyperoxic 411 565.5 677 37.6% +/- 73% 64.7% +/- 104% 
Gradient 104 113 119 8.65% +/- 7.1% 14.4% +/- 3.59% 
Hypoxic 170 178 173 4.71% +/- 5.6% 1.76% +/- 17.8% 
 
As can be seen in the average percentages after 48 hours in Table 5, the hyperoxic region 
had the most proliferation at approximately 64.72%. The gradient saw the next highest 
proliferation with an increase of approximately 14.40%. There was not much proliferation in the 
hypoxic region. 
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The data for the intermediate experiments can be seen in Table 6. The cell counts for 
each environment (hyperoxic, gradient, and hypoxic) can be seen along with the percent 
increase. 
 
Table 6: Intermediate Experiment Cell Proliferation 
 
0 
hours 
24 
hours 
48 
hours 
% Increase After 24 
hours  
% Increase After 48 
hours 
Hyperoxic 174 227 302 30.5% 73.6% 
Gradient 358 401 415 12.0% 15.9% 
Hypoxic 318 332 343 4.40% 7.86% 
Total 563 960 1,060 
   
 The hyperoxic region saw the most proliferation at approximately 73.56%, followed by 
the gradient which saw 15.92% increase in cell number. The hypoxic saw the least proliferation 
at approximately 7.86%. 
The entire gradient of the shallow 5mm gradient could not be visualized. The top gradient 
was imaged. This is the area between the air chamber and the middle chamber (top of the 
gradient). For the two experiments, the top reference point cell numbers were averaged and can 
be seen in Table 7. 
 
Table 7: Top Gradient of Shallow 5mm with Averages 
 
0 hours 24 hours 48 hours 
Experiment #1 901 878 906 
Experiment #2 221 154 162 
Average 561 516 534 
 
 The completely  hypoxic and hyperoxic regions of a the device were imaged and the cell 
count was analyzed. This data can be seen in Table 8 below in combination with the top gradient 
data from Table 7. The cell percent increases were calculated. 
 
Table 8: Shallow Gradient Cell Proliferation 
 
0 
hours 
24 
hours 
48 
hours 
% Increase After 24 
hours  
% Increase After 48 
hours 
Hyperoxic 310 289 330 -6.77% 6.45% 
Top 
Gradient 561 516 534 -8.02% -4.81% 
Hypoxic 356 301 319 -15.4% -10.4% 
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As can be seen from the table, there was not much proliferation in any of the shallow 
region. The only percent increase in cell number was in the hyperoxic region. The numbers 
stayed relatively consistent, so little to no proliferation occurred.  
 
 The data from Tables 3-8 above was normalized. The time point of 0 hours was 
considered to have a cell count of 100%. The percent increases/decreases seen in the Tables was 
added/subtracted from 100%. To visualize the increase or decrease in cell number, the data was 
plotted for each of the three gradients.  
 
Figure 30: Average Shallow (5mm) Gradient Cell Proliferation Over 48 Hours 
 
 
Figure 31: Intermediate (700µm) Gradient Cell Proliferation Over 48 Hours 
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Figure 32: Average Sharp (100µm) Gradient Cell Proliferation Over 48 Hours 
 
 For all three gradients, the most proliferation was observed in the hyperoxic regions. Cell 
count increased by approximately 60% in the sharp and intermediate gradients. There was a 
moderate amount of proliferation in the gradients for the sharp and intermediate gaps 
(approximately 20%). The least amount of proliferation was seen in the hypoxic regions.  
5.3 Migration 
To visualize the migration, images at 0 hours and 48 hours were overlaid and aligned. 
However, it was deemed more accurate to quantify migration distance by using the individual 
overlaid image (of the fluorescent image of focused cells and the image focused on the reference 
point) at 0 hours and at 48 hours, and measuring the distance that the cells migrated. This was 
done by drawing the line measure tool in FIJI to the same location. This process can be observed 
within the first two columns in the Figure below (Figure 33). Approximately fifteen random cells 
were observed in each of the three regions (hyperoxic, gradient, hypoxic) of one device at 0 
hours and 48 hours. Images were zoomed in to get a more accurate measurement (Figure 34). 
The scale was set such that 0.53 pixels was a micrometer. This was found by using the 200 
micrometer scale in the image. On the 0 hour image, a line was drawn from the middle of the cell 
to a reference line. The same was done for the 48 hour image- the same cell was found and a line 
was drawn to the same reference line. The migration calculations were done for the sharp and 
intermediate gap devices. It could not be done for the shallow gradient, because the entire 
gradient wasn’t visible within the microscope field of view.  
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Figure 33: Overlay process. Reference point and focused fluorescent cells are overlaid into an image, such as that 
seen at 0 hours or 48 hours. These two images are then overlaid and aligned to observe migration. (This method was 
not used to calculate the migration). 
 
 
     0 hours          48 hours 
Figure 34: Migration Measurement in FIJI. FIJI analysis using the measure tool to observe how far cells migrated by 
comparing cell distance to the same location on the reference point. 
 
 The migration of approximately fifteen random different cells was measured (Tables 9 
and 10). The length of the cell was measured to a reference point (length 0 hours). The same cell 
was measured to the same reference point (length 48 hours). These measurements are the cell in 
relation to the reference point. The length moved was found by subtracting these numbers. It was 
recorded which way the cell moved; up was indicated by a positive number and down was 
indicated by a negative number. This up and down movement is in referral to the gradient the 
cell moved toward. A positive number is toward the hyperoxic region and a negative number is 
toward the hypoxic region (Figure 35).  
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Figure 35: Image to show how positive is up to the hyperoxic environment and negative is down to the hypoxic 
environment. 
5.3.1 Sharp 100µm Gradient Migration 
 The data gathered on the migration of the cells in the sharp environment can be seen 
below. The length moved for each region is bolded. A positive number means movement to a 
higher oxygen gradient, and a negative number means movement to a lower oxygen gradient.  
 
Table 9: Sharp Gradient Migration 
Hyperoxic Gradient Hypoxic 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
204.6 203.0 -1.6 20.12 25.15 -5.03 35.21 35.22 0.01 
39.75 47.79 8.04 42.76 37.73 5.03 50.37 47.79 2.58 
129.0 138.3 9.3 57.91 52.80 5.11 70.43 60.43 10 
213.3 213.8 0.5 27.70 42.76 15.06 30.10 27.67 2.43 
322.6 334.6 12 15.09 10.06 5.03 196.3 193.7 2.6 
324.8 334.6 9.8 57.91 60.03 -2.12 103.1 105.6 -2.5 
34.80 42.76 7.96 72.99 75.51 -2.52 334.7 332.0 2.7 
74.44 80.50 6.06 32.70 35.22 2.52 337.1 327.1 10 
47.12 64.26 17.14 10.37 7.955 2.415 788.5 785.9 2.6 
704.7 701.9 -2.8 65.40 65.50 0.1 708.1 704.6 3.5 
168.5 178.6 10.1 75.46 83.01 7.55 72.95 65.40 7.55 
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35.30 40.70 5.4 62.90 52.89 10.01 511.0 510.9 0.1 
377.3 402.5 25.2 95.59 85.53 10.06 226.5 223.0 3.5 
691.8 706.9 15.1 37.73 47.79 10.06 359.7 359.7 0 
178.6 186.1 7.5 
   
470.4 465.4 5 
135.8 140.8 5 
   
650.2 651.8 -1.6 
Average 
 
8.418 
  
4.520 
  
3.029 
 
 The most migration was observed within the hyperoxic region of the sharp device. Cells 
moved an average of 8.418 +/- 7.01µm. They moved higher into the hyperoxic region toward 
higher oxygen levels. The cells within the gradient moved an average of 4.52 +/- 5.72µm. These 
cells moved toward higher oxygen levels toward the hyperoxic region. A few cells moved down 
toward the more hypoxic region. The cells in the hypoxic region moved an average of 3.029 +/- 
3.67µm. These cells moved the least. The data in the table was created into plots for the three 
different environments of the sharp gradient. These plots can be seen in Figures 36-38 below. 
 
Figure 36: Migration on the Oxygen Gradient in the Hyperoxic Region of the Sharp Device Over 48 Hours. A 
positive number represents movement into a higher oxygen gradient and a negative number represents movement 
into a lower oxygen gradient.  
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Figure 37: Migration on the Oxygen Gradient in the 100µm Gradient Region of the Sharp Device Over 48 Hours. A 
positive number represents movement into a higher oxygen gradient and a negative number represents movement 
into a lower oxygen gradient.  
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Figure 38: Migration on the Oxygen Gradient in the Hypoxic Region of the Sharp Device Over 48 Hours. A positive 
number represents movement into a higher oxygen gradient and a negative number represents movement into a 
lower oxygen gradient.  
 
 To make the information of each region clearer than the individual plots in Figures 36-38, 
the plot in Figure 39 below shows the average migration on the oxygen gradient. The migration 
in the hyperoxic, gradient, and hypoxic regions can be seen.  
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Figure 39: Bar Graph of the Average Migration on the Oxygen Gradient in the three different regions of the Sharp 
Device Over 48 Hours.  
 
 As can be seen in Figure 39, the average migration in all three regions was positive. This 
means that the cells moved toward more oxygen. The cells within the hyperoxic region moved 
most; these cells moved to a higher region of oxygen (more hyperoxic). The standard deviation is 
also plotted within the graph.  
5.3.2 Intermediate 700µm Gradient Migration 
The data gathered on the migration of the cells in the intermediate environment can be 
seen below. Again, a positive number means movement to a higher oxygen gradient, and a 
negative number means movement to a lower oxygen gradient. 
Table 10: Intermediate Gradient Migration 
Hyperoxic Gradient Hypoxic 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
Length 0 
hours 
Length 48 
hours 
Length 
moved (µm) 
52.78 55.35 2.57 77.9 72.93 4.97 133.3 138 4.7 
274 271.5 -2.5 83.1 57.8 25.3 243.8 246.3 2.5 
394.6 394.7 0.1 85.49 85.45 0.04 434.9 439.9 5 
85.5 93 7.5 334.36 339.3 4.94 15.1 17.6 2.5 
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63.8 67.86 4.06 155.8 145.8 10 143.8 145.8 2 
241.5 248.9 7.4 173.4 171 2.4 37.7 40.2 2.5 
115.6 120.6 5 88 83 -5 62.9 60.3 -2.6 
135.7 148.3 12.6 110.6 105.6 -5 334.3 336.8 2.5 
243.8 238.8 -5 148.3 145.7 -2.6 346.9 349.4 2.5 
248.9 246.4 -2.5 27.6 50.3 22.7 374.6 367.2 -7.4 
261.6 268.9 7.3 55.5 55.8 0.3 155.8 163.4 10.54 
326.8 321.7 -5.1 173.4 173.4 0 168.5 171 2.5 
329.3 329.2 -0.1 372.1 374.5 2.4 513.1 513 -0.1 
515.3 521.8 6.5 384.5 377.1 -7.4 384.9 392.3 7.4 
550.5 543 -7.5 90.5 90.5 0 377.3 379.5 2.2 
52.78 55.35 2.57 77.9 72.93 4.97 133.3 138 4.7 
Average 
 
2.022 
  
3.537 
  
2.449 
  
 For this device, the most migration was observed within the 700µm gradient region. Cells 
moved an average of 3.537 +/- 9.41µm. They moved higher into the hyperoxic region toward 
higher oxygen levels, but some moved downwards. A couple cells moved especially far 
(approximately 20+µm). The cells within the hyperoxic moved an average of 2.022 +/- 5.81µm. 
A few cells moved down toward the more hypoxic region. The cells in the hypoxic region moved 
an average of 2.50 +/- 4.06µm. None of the cells in any of the environments moved too much on 
average. The most migration was seen in the gradient. The data in the table was created into plots 
for the three different environments of the intermediate gradient. These plots can be seen in 
Figures 40-42 below. 
    48 
 
Figure 40: Migration on the Oxygen Gradient in the Hyperoxic Region of the Intermediate Device Over 48 Hours. A 
positive number represents movement into a higher oxygen gradient and a negative number represents movement 
into a lower oxygen gradient.  
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Figure 41: Migration on the Oxygen Gradient in the Gradient Region of the Intermediate Device Over 48 Hours. A 
positive number represents movement into a higher oxygen gradient and a negative number represents movement 
into a lower oxygen gradient.  
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Figure 42: Migration on the Oxygen Gradient in the Hypoxic Region of the Intermediate Device Over 48 Hours. A 
positive number represents movement into a higher oxygen gradient and a negative number represents movement 
into a lower oxygen gradient.  
 
Again, to make the information of each region clearer than the individual plots in Figures 
40-42, the plot in Figure 43 below shows the average migration on the oxygen gradient. The 
migration in the hyperoxic, gradient, and hypoxic regions can be seen along with the standard 
deviation error bar.  
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Figure 43: Bar Graph of the Average Migration on the Oxygen Gradient in the three different regions of the 
Intermediate Device Over 48 Hours.  
 
 As can be seen in Figure 43 above, the average migration in all three regions was 
positive. This means that the cells on average moved toward more oxygen. The cells within the 
gradient region moved most; these cells moved to a higher region of oxygen. The standard 
deviation is also plotted within the graph. The standard deviation is particularly high because as 
can be seen in Table 10, the cells did not move that much on average. Additionally, some cells 
moved up and some moved down. The movement was much more randomized than was seen in 
the 100µm gradient. On average, the cells tended to move upwards two to three micrometers.  
5.3.3 Shallow 5mm Gradient Migration 
 Unfortunately, there is no table or plots of migration within the shallow gradient since it 
could not be observed within the field of view of the microscope. Upon inspection of the cells in 
the hyperoxic and hypoxic gradient there was little to no movement. Within the gradient it was 
unclear if there was migration, proliferation, death, or all three. 
5.3.4 Overlaid Images of Cells Within Three Different Gradients 
 Overlaid images of 0 hours and 48 hours can be seen for each of the three 
gradients.  These images were aligned using FIJI. 
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 Figure 44 shows the overlay done for the sharp 100 µm gradient. The yellow cells are 
from 0 hours and the blue ones are from 48 hours. The large amount of proliferation is visible. 
The image is not completely aligned; the rotation is slightly off. If it could have been rotated, the 
migration would have been more obvious.  
 
 
Figure 44: Sharp 100 µm gradient Overlay of 0 and 48 Hours 
 
Figure 45 shows the overlay done for the intermediate 700 µm gradient. The red cells are 
from 0 hours and the blue ones are from 48 hours. The large amount of proliferation is visible 
within this device as well. The blue cells tend to move upwards toward the hyperoxic region. 
(Will fix this one too). 
 
Figure 45: Intermediate 700 µm gradient Overlay of 0 and 48 Hours 
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Figure 46 shows the overlay done for the shallow 5mm gradient. This is located at the 
bottom gradient (nitrogen is in the chamber directly below).The red cells are from 0 hours and 
the green ones are from 48 hours. There are some red cells which shows no movement, but there 
are also a lot of red and green cells. It is unclear if these cell migrated, because only part of the 
gradient is being observed and few cells seem to correlate. The ones that do appear as if they 
moved up. This would go along with the rest of the conclusions- that the cells will move to a 
higher level of oxygen.  
 
Figure 46: Shallow 5mm gradient (bottom) Overlay of 0 and 48 Hours 
 
 The migration and proliferation at the inlets and outlets was also observed. It was found 
that imaging at these locations had little to no effect on the migration or proliferation; it generally 
stayed consistent to what was found for each gradient. 
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6. Final Design & Validation 
 The final design aspects including its fabrication, components and validation are included 
in this chapter.  
6.1 Fabrication of Devices 
 A silicon master was created by the microfabrication lab at WPI using the design created 
on DraftSight. The master was made by photolithography. It can be seen in the Figure 47 below. 
To create the devices, 100g of silicone base and 10g of curing agent were measured out and then 
mixed properly in a large weigh boat. The solution was degassed in a vacuum. After fully 
degassing the PDMS, it was poured onto the silicone master that was contained in a large 
140mm X 20mm petri dish. The PDMS was carefully poured in a back and forth motion to 
minimize the number of bubbles within the master. Then a plastic pipette was used to remove 
any dust and bubbles that would reside within the device. The dish was then placed in the 
incubator at 60°C overnight. The silicone master was removed from the oven the following day. 
To remove the devices from the cured master, a scalpel was used. When cutting the devices out, 
a circular shape was made and cut in such a way as to ensure that the master was not cut out with 
the devices. After the devices were removed, they were individually cut out. The next time 
devices were made, they were made in the same way, except only 50g of silicone base and 5g of 
curing agent was mixed properly and poured onto the master once degassed. 
 
Figure 47: Silicone Master and part of the DraftSight model 
 
Before plasma bonding, the microfluidic device and membrane were cleaned thoroughly 
with ethanol. Tape was used on the device, slide, and membrane to remove any dust. The first 
components that were plasma bonded were the devices to the slides. The slide was facing up and 
the system was facing down. The slide was flipped onto the bottom of the device and was plasma 
bonded. Next, the device was placed with the system facing up and the membrane next to it on 
    55 
the tray slide. A drop of ethanol was placed between the membrane and the tray slide, to ensure 
easy removal from the tray slide. 
6.1.1 Fabrication of a 50 µm membrane using PDMS 
A membrane will be made out of PDMS which will allow the oxygen of the system to 
permeate the hydrogel and cells. 
In order to make the membrane, the team started by placing a small weigh boat on the 
balance and measured 5g of silicone base. Then 0.5g of the silicone curing agent was measured. 
By using a Popsicle stick, the base and curing agent was mixed thoroughly for at least two 
minutes. Bubbles formed at this point. Once mixed thoroughly, the weight boat was placed 
inside a vacuum chamber and turned on. Bubbles were observed rising to the surface of the 
mixture. The spigot was used to release the vacuum slowly to pop any bubbles (some bubbles 
were blown lightly to pop). This process took about fifteen to twenty-five minutes. A strip of 
0.25mm scotch tape was added to the length side of the fluorinated slide, size 75mm x 
50mm. The fluorinated slides were placed on aluminum foil, and the fluorinated side was made 
sure to be facing up. Once there were no bubbles in the mixture the PDMS mixture was then 
poured onto the slide, slowly in a side-to-side motion to avoid forming bubbles. Once the entire 
slide was covered in PDMS, the other fluorinated slide was placed on top, which covered the 
PDMS mixture between both slides. It was important to make sure that the fluorinated slide was 
facing down. The slides were pressed down on until the PDMS mixture spread evenly between 
the slides. Used binder clips to keep a tight seal between the slides.  Next, the slides were 
cleaned on the sides of the slides from the extra PDMS mixture and the slides were then placed 
onto a clean aluminum foil sheet. The aluminum foil was wrapped around the slides and placed 
in the oven at 60°C which they were left overnight.  
 
Removing 50µm PDMS membrane from the fluorinated slides 
The PDMS mixture within the fluorinated slides was taken out of the oven after being left 
overnight. The aluminum foil was opened up and a straight edge razor blade was used to cut in 
the corner and gently lift the slide up to avoid damaging the membrane. This was done to each 
corner to easily remove the top slide without damaging the membrane. Once the top slide had 
been removed, the PDMS membrane on the bottom slide was cut along the tape edge using the 
straight edge razor blade; this helped remove the PDMS membrane from the slide. Once the 
membrane was removed from the slide, it was placed in a safe location to avoid damaging it. The 
membrane was then measured and kept within a taped petri dish. 
6.1.2 Fabrication of Wells 
 The wells were fabricated similarly to the membranes. A large weight boat was used to 
mix 70g of silicone base with 7g of silicone curing agent. These were stirred together with a 
popsicle stick and degassed in a vacuum chamber. After there were no more bubbles, the weigh 
boat was placed into the oven at 60°C overnight. The next day rectangular squares roughly the 
same size as the device were cut out. From there, the correct measurements to expose the system 
were drawn onto the rectangle and cut out using a straight edge razor. The height of the well was 
then measured. 
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6.2 Device Sterility 
The device was sterilized by rinsing it with ethanol. Dust was removed by wiping it with 
a kim-wipe and then blowing air onto it. The device, which is plasma bonded to the slide and 
membrane, a well, and a cover slide of glass was placed in ultraviolet light for approximately 
two hours	  before seeding cells and hydrogel.	  
6.3 Cells Seeded 
The number of cells to seed is 200,000 cells. If a plate has been culturing for 5 days, the 
approximate volume would be 75uL after passaging. This number of cells was selected because 
it allows room for proliferation and migration to be observed under the microscope. Below is an 
image that compares 200,000 cells to 2 million. 
	  	  	   	  
Figure 48: 2 Million Cells Seeded in PureCol EZ (left) versus 200,000 Cells Seeded in PureCol EZ 
6.4 Gas Gradient Validation 
During the gas test an OceanOptics Ruthenium- coated slide was used to observe the 
change in oxygen levels. As shown on the image (Figure 24) the brighter area is the decrease in 
oxygen levels caused by the carbon dioxide being blown onto the slide.  
To observe an oxygen gradient in the device, an image was taken before the gases were 
turned on and another image was taken when the gases were flowing after the gradient was 
stabilized. The top chamber inlet was compressed air and the middle chamber was 
nitrogen/carbon dioxide to observe a gas gradient through the device.  
6.5 Cell Viability in Chosen Hydrogel 
 PureCol EZ Bovine Collagen Solution was chosen as the hydrogel to use because 
preliminary experiments concluded that MDA-MB-231 can proliferate and migrate in the 
hydrogel. Cells were observed under the blue light of the fluorescent microscope. The GFP of 
the genome fluoresces under this light. Cells remained viable as the GFP was present and 
observable (Figure 12). 
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6.6 Device, Cells, & Hydrogel 
200,000 MDA-MB-231 cells were seeded in 1mL of PureCol Ez hydrogel. After the 
hydrogel solidified, 1mL of media was placed inside the well. The device with all components 
was placed in the incubator. This included the device, well, hydrogel, cells, media, and glass 
cover slide. Compressed air was flown through the top chamber and nitrogen gas was flown 
through the middle chamber or bottom chamber depending on the gradient being produced. 
Three different gradient experiments were conducted. The experiment ran for 48 hours and 
media was replenished if necessary. The cells were imaged at 0 hours, 24 hours and 48 hours. 
Using FIJI, the images were compared to observed migration and proliferation. 
6.7 Imaging 
The device and cells were imaged using the ZEN program with the Zeiss Axiovert 40 
CFL Fluorescent microscope. The FIJI image analysis program was used to analyze the 
proliferation and migration images, which were saved as ome.tiff. 
 Proliferation images were analyzed for each experiment at 0, 24, and 48 hours. It was 
further broken down by the region (hyperoxic, gradient, hypoxic). The fluorescent image was 
added to FIJI and the background was subtracted through the threshold adjustment. Watershed 
was added to break up the clumped cells. The particles were then analyzed.  
 Migration images were analyzed by combining the image of the reference point and the 
focused fluorescent cells. Initial images from 0 hours were compared to the 48 hour images. 
Fifteen cells within each region (hyperoxic, gradient, hypoxic) were measured; this measurement 
went from the middle of the cell to a reference point for both timepoints. The direction of 
movement was noted and the length difference was calculated. To overlay these images the 
“align RGB stack” plug in was installed. This allowed the images to be aligned. 
6.8 Economics 
The team received the MDA-MB-231/GFP/Blasticidin cells from Professor Ambady as a 
gift. The team was gifted a new master mold with the alternative designs from the 
microfabrication lab and BME595T course at Worcester Polytechnic Institute. The team 
purchased a compressed air tank, a nitrogen gas tank and carbon dioxide gas tank at a total cost 
of $111.00. The team started with a budget of $500 and after purchases ($311) had a final budget 
of $189 remaining. 
The microfluidic device would help in reducing the cost of each experiment. The cost to 
fabricate one device with its components is $22.  The capability to reuse each device helps in 
reducing the cost of buying multiple devices for experiments. One silicone master can be reused 
to make multiple devices. The suggested amount of cells, hydrogel and media for each 
experiment is lower compared to other methods of 3D culturing at a total of $40. Providing a low 
scaled 3D environment with similar oxygen levels as the body can aid in cell biology and drug 
treatments. This capability will affect the market by introducing more drug treatments if the 
device is successful in the research.  
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6.9 Environmental Impact 
The microfluidic device can be reused after it is proper cleaned. This helps decrease the 
amount of culturing plates thrown away after one use. The device is capable of culturing cells for 
48 hours. The cells, hydrogel and media will be disposed of in the biohazard waste at the end of 
each experiment. 
6.10 Societal Influence 
The microfluidic device could be helpful in a research environment that requires oxygen 
gradients that closely mimic in vivo environment to further advance cell biology and drug 
discovery.  With further experiments, the microfluidic device can be an important tool for this 
field of research. As of right now, there are improvements and validations necessary to provide 
the best outcome. If this device were to be useful in furthering cancer cell biology, alternative 
treatments for cancer could be discovered. This would greatly affect the population and increase 
life expectancy. People, their families, insurance companies, doctors, cancer research facilities, 
etc. will all be impacted by finding a cure for cancer. 
6.11 Political Ramifications 
The microfluidic device was designed to be used in a research environment that requires 
an oxygen gradient that closely mimic in vivo for cell biology and drug discovery. With this in 
mind, it would not have an impact to the global economy since the market for this type of 
research is small. If a new drug discovery is successful in using the device, it will provide a new 
addition to the market in that treatment field. The political ramifications are likely to be minimal. 
6.12 Ethical Concerns 
The microfluidic device was designed to closely mimic in vivo environment and will help 
reduce the usage of mice or other animals in testing. The device will provide an alternative 
method to observe cell biology and drug discovery as long as the cells can be cultured and 
produced in the design. Ethically speaking, several people may find cures for cancer to be 
unnatural. If cancer cell biology is furthered and a cure is discovered, there will be less deaths 
due to cancer. This would cause a population rise. Cancer may be seen to many as a means of 
controlling the population.  
6.13 Health & Safety Issues 
The design is made of PDMS which if handled properly will not be toxic to any of the 
people involved in the fabrication of each device. Cells, hydrogel, and media will have to be 
handled properly to prevent any contamination in each experiment. The microfluidic device also 
needs to be properly cleaned and sterilized before beginning each experiment to prevent any 
contamination from occurring. 
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6.14 Manufacturability 
The only materials needed to manufacture the devices are a silicone master in a 120mm 
petri dish, a 184 Sylgard silicone kit, a vacuum chamber, and a oven. These can all be bought at 
once and can be reused except for the 184 Sylgard silicone kit, which would need to be bought as 
it is used.  
6.15 Sustainability 
The microfluidic device is made from a silicone master that can be reused to produce 
many devices. After each experiment, the device can be cleaned properly to be reused by 
following the cleaning and sterilization protocol. As long as the protocol is followed carefully, 
the devices should last for 20 to 25 experiments before seeing some deterioration on the 
membrane.  This will benefit the personnel involved by allowing multiple experiments before 
needing to fabricate more devices from the silicone master. 
6.16 Final Design Discussion 
In the final design, proliferation and migration were observed within the different oxygen 
gradients. While three gradients were tested, the best design was the 100 micrometer sharp 
gradient. The most proliferation occurred within the hyperoxic region of this gradient and 
migration in the hyperoxic region was furthest, but there was obvious migration within the 
gradient and hypoxic regions as well. Although the cells could migrate on the Z-plane of the 
hydrogel making it difficult to focus on the same cells, the proliferation percentage and 
migration average in each region of the device were calculated. To avoid this complication, it is a 
possibility to stain the cells that were first seeded. This will allow for easier tracking when 
focusing under the microscope and observe if the cells are in the same plane. Once the initial 
cells are seeded, using a different stain on the hydrogel would help track of any proliferation. 
New proliferated cells should express the new stain it was exposed to and observed under the 
microscope. These are a few improvements to better validate proliferation and migration was 
observed in the oxygen gradient.  
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7. Discussion 
This chapter discusses the results of the gas tests and cell response in the three different 
gradients.  
7.1 Device  
 The objectives of Chapter 3 were accomplished throughout the year. The team tested 
three different oxygen gradients: a shallow, an intermediate, and a sharp gradient. A new 
microfluidic device was designed and created to produce the 700 micrometer gradient. It was 
believed that this gradient would produce the best results; however, the sharp gradient was 
deemed the best as the most migration and proliferation occurred. The hydrogel used was able to 
simulate a 3D environment effectively.  
 Different gases were able to flow through the microfluidic device. The nitrogen gas 
produced a hypoxic environment and the compressed air produced a hyperoxic environment. 
Between these two chambers, a gradient was produced. The oxygen gradients could be observed 
and quantified based on the amount of fluorescence that was observed under the microscope. It 
would have been nice to have more accurate quantifications, but the fluorescent slide worked 
well. The other devices to measure oxygen were too expensive and out of budget. 
 The microfluidic devices allowed simultaneous observation of the cancer cells in the 
hypoxic, gradient, and hyperoxic environments. This allowed the team to directly test the 
viability, proliferation, and migration within one device.  
 The fabrication of one device cost about $22, which means it was cost efficient. This 
includes the PDMS device, PDMS well, PDMS membrane, hole puncher, and glass slide. Once 
fabricated all of these components are reusable. This does not include the cost of the master. To 
run an experiment would cost approximately $47. This includes the device components, the cells, 
PureCol EZ hydrogel, Complete Media, and the pipette, and gas components such as the tubing, 
needles, pins, and luer locks. These prices do not take the gas tank costs or the costs to run the 
incubator into account. Additionally, a fluorescent slide and microscope are needed to analyze 
the cells, but again, these are not included. For more information on the prices of the experiments 
see Appendix D.  
 It was predicted that the cancer cells would thrive in a high oxygen environment and 
would proliferate the best under these conditions. From the experiments it was determined that 
the MDA-MB-231 breast cancer cells grow best in hyperoxic (high oxygen) environments and 
will migrate to this higher level of oxygen when in a sharp enough gradient. 
7.2 Gas Test on the Fluorescent Slide & Within the Device 
The gas test on the fluorescent slide produced results as expected. The carbon dioxide 
flow can be clearly seen and the shape of the fluorescence was also expected. 
 While it took many hours and iterations to capture relevant, useful images of the gas flow 
within the device, the images in Figure 26 perfectly represent the gradient produced for the 100 
and 700 micrometer gradients. The thickness of the membrane affected how long it took for the 
gradient to be established.  As membrane thickness increased, time to establish the gradient 
increased. The device was pressed directly onto the glass fluorescent slide, which could be a 
reason why the diffusion time was longer. Instead of diffusing through both the membrane and 
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through the thin chamber gaps, the slide made it more difficult to diffuse through the membrane, 
since it could only reach the slide. It would have been helpful to create a gas test simulation of 
the gradient through the hydrogel. This could have been tested with water, however, it was too 
difficult to make a really thin well that effectively held the water within the device. This could 
have been done if the microscope did not observe the device from the bottom-up; using an 
inverted microscope would have been much easier for this task. It would have been helpful to 
confirm that the 5mm gradient was produced.  
 The precise oxygen sensors were outside of the team’s budget. These would have been 
useful to further confirm that the gradients seen in the COMSOL models and gas tests within the 
device were being produced. This would have quantified the oxygen gradients. Overall, the 
oxygen gradients were successfully produced in the device.  
7.3 Proliferation, Migration, and Viability 
After testing across a shallow 5mm gradient and a sharp 100µm gradient, COMSOL 
modeling and research led the team to create an intermediate 700µm gradient. It was predicted 
that the cells would have a more gradual gradient to respond to than in the 100µm, but sharp 
enough for the cells to acknowledge a sense of the gradient as opposed to in the 5mm gradient. 
Within the trials run, it appeared that the sharp gradient produced the most migration and 
proliferation of the three gradients. The cells within the hyperoxic region of the sharp gradient 
migrated approximately 8.4µm toward an even higher oxygen level on average. Some cells were 
able to migrate close to 25µm. It is possible that the cells were able to easily signal the sharp 
change in oxygen concentration. The intermediate gradient had migration, but it was not as much 
as was seen in the sharp gradient. This could be because the gradient was too wide for the cells to 
really get a sense of the change in oxygen concentration. If that was the case for the intermediate, 
then it further concludes why we did not observe clear migration in the shallow gradient. The 
cells within the intermediate gradient tended to have more randomized movement (as the 
standard deviation bars are quite large). From the results it appears that the cells moved to a 
higher level of oxygen on average. Some cells within the gradient moved to a more normoxic 
region of the device. This could have been because these oxygen levels closely resemble what is 
seen in the body, or the cells may not have been able to effectively sense and respond to the 
gradient. This would cause more randomized, natural movement. 
Research shows that cells will migrate around four micrometers in twelve hours in a 2D 
gradient (Chang et al, 2014). Cells moved linearly through the gradient, but it was also observed 
that they moved up and down within the hydrogel. This could not be measured. Also, some cells 
showed side-to-side movement within the gradient. These values were not calculated since there 
was no movement to a different gradient. Since the cells were observed under the 5X 
magnification, this small amount of movement is difficult to clearly see. When calculating the 
migration lengths using FIJI, the scales were set to the same and extreme caution was taken in 
making sure the line went from the middle of the cell to the reference point of choice. With this 
being said, there still could have been some human error. 
The most proliferation was also seen within the hyperoxic region of the sharp device 
(experiment #1) with an increase of approximately 167%. The population more than doubled. 
Extreme care was taken to make sure that the images taken at each time point closely resembled 
the image taken at the previous timepoint. Close care was taken in ensuring that the images were 
straight and even (same amount of hyperoxic chamber visible as hypoxic chamber).  In 
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experiment #1’s case (or in any of the cases), it is possible that the high amount of proliferation 
was correlated to a slight shift in the image. If more of the hyperoxic region was imaged, that 
means that less of the hypoxic region was imaged, and would thus look like an increase for the 
hyperoxic region and a decrease for the hypoxic region. This is why alignment was so important. 
The gradient region would be unaffected by this though, because it was always in the middle of 
the image. There also could be some human error involved in calculating the proliferation on 
FIJI. For each image the threshold had to be adjusted. These values were kept relatively the 
same, but each image was different because the brightness of the cells/image varied. Great care 
was taken in making sure that all cells were properly visualized for the cell count; this meant that 
not all thresholds were the same.  It is odd that the cells in the hyperoxic region of the shallow 
gradient did not proliferate. This could be due to image alignment, that less cells were in the 
region, or that cells did not migrate there, and therefore did not increase the cell number within 
the region. 
 Migration measurements were not affected by misalignments of images, but the overlay 
images of 0 and 48 hours were. When using FIJI, the images could be aligned side to side and up 
and down, but they couldn’t easily be rotated. If the image was rotated a few degrees, the 
migration in these overlays would be more visible.  
 Only a few experiments were run for each gradient because of time constraints. Some 
experiments failed. These included: a leaking well and a hydrogel that peeled away from the 
bottom of the device because it was too thin. More experiments would be useful to further 
confirm the data and conclusions.  Additionally, moving the device outside of the incubator for 
an hour out of the forty eight probably was not enough to affect the growth and migration of the 
cells, but it may have. 
Through this project, breast cancer cell biology was furthered. Even though migration 
was slight, it can be observed that cells will migrate to a higher oxygen level of up to 21% if it is 
available. Additionally, cells will proliferate more in these conditions. It is likely that cells in a 
lower oxygen environment (hypoxic) have less “fuel.” At lower oxygen concentrations than 
normal, cell function is affected. Cancer cells can grow in hypoxic conditions, but that does not 
mean that it is a preferred condition. The fact that there was slight proliferation in the hypoxic 
regions proves that cancer cells can grow in low oxygen.  
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8. Conclusions & Recommendations 
 This chapter summarizes the findings and the conclusions of the project, and the 
recommendations for further improvement. 
8.1 Conclusions 
Oxygen gradients were produced and created in the designed device. These gradients 
were apparent in the sharp and intermediate gradients. There was a visible difference in color 
between the channel with nitrogen gas (hypoxic) and the channel with compressed air 
(hyperoxic). Within the middle of these chambers was a gradient that produced a color change 
comparable to what was modeled in COMSOL. Additionally, the region of the sharp gradient 
had a much quicker shift in color than the intermediate gradient; this makes sense. The oxygen 
gradient in the 5mm gradient could not be accurately imaged using the microscope, since the 
5mm gradient was outside the 2mm range of view that could be see under the 5X magnification, 
however, it was assumed that this gradient was produced.  
 The breast cancer cells were properly cultured over a duration of five months; no 
contamination was ever observed.  
The migration and proliferation in the device was less than expected, but it could still be 
observed. The most migration overall was seen within the sharp 100µm gradient. Overall each 
cell moved approximately 5µm to a higher oxygen gradient. The hyperoxic region had the most 
migration. On average cells moved about 8.5µm to an even higher oxygen level; some cells 
moved as much as 20µm within this region. The gradient saw more migration to a higher level of 
oxygen than the hypoxic region; the cells within the gradient moved an average of 4.5µm, and 
the cells within the hypoxic region moved an average of 3µm. It is likely that the cells within a 
higher region of oxygen had more fuel to allow them to migrate and proliferate. There was 
migration within the intermediate 700µm device, but it was less than what was seen in the sharp. 
Cells within all regions of the device migrated an average of about 2.75µm to a higher level of 
oxygen. The shallow gradient had movement, but it was unclear if it was from proliferation or 
migration, since the whole 5mm gradient could not be observed at once under the microscope. 
There was also movement within the hyperoxic and hypoxic regions of the device, but again it 
was unclear if the cells had moved out of the region, proliferated, or even died.  
 As far as proliferation goes, it was concluded that the most proliferation occurred within 
the hyperoxic regions on average. These oxygen levels were higher than what is normally seen in 
the body. It makes sense that cancer cells would find this higher oxygen environment attractive 
since they use a lot of oxygen. Additionally, the oxygen levels within the incubator are 
approximately 17% oxygen (in a 5% CO2 incubator) (BioSpherix, n.d.). This means that the 
cells are used to proliferating in this higher level of oxygen. There was little to no proliferation 
seen in the shallow gradient; the cell numbers remained relatively the same. There was much 
more proliferation seen in the intermediate and sharp gradient devices. Within the hyperoxic 
regions, the cell count increased by approximately 60-70%. In the gradient region of these 
devices, there was a cell count increase of approximately 20%. The hypoxic regions had a cell 
count increase of only 5%; this can conclude that there was little to no proliferation in this 
region.  
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 Overall, the 100µm device had the most proliferation and migration observed. Lastly, all 
devices are reusable and can be used to culture other cell lines. Different gases, or even small 
volumes of liquid can potentially be flown through the device. 
8.2 Recommendations 
In order to build upon the achievements of the device and the results that were found 
during this project, there are a few recommendations for future work. Using an expensive oxygen 
sensor would allow for the oxygen levels to be quantified more precisely. These were outside of 
the budget, but would further confirm that the oxygen gradients were produced especially if they 
could be done within the hydrogel. 
It would be useful to better control the atmospheric oxygen interference. The incubator 
has an oxygen concentration of about 17%, so it would be useful to use a hypoxic incubator that 
contains much less oxygen. Utilizing an incubator that has only 5% oxygen would be a drastic 
difference. Additionally, the device was covered by a glass slide on both ends, however, the 
sides were remained untouched. Since it is possible that oxygen could have diffused through the 
PDMS (even though it was thick), the device can be entirely encased in glass for the future. 
Using media that is oxygen free would also decrease interference.  
 The cells were observed under the 5X magnification lens. This was because the device 
and all the added components made the device quite thick. A thinner device could be made in the 
future; this could allow the cells to be focused on under a higher magnification such as 10X. 
Additionally, cells could be more uniformly distributed throughout the gel. 
 The migration and proliferation were difficult to accurately observe since cells under a 
higher magnification couldn't be observed, and it was difficult to properly align the reference 
point at each time point. A way to live track the cells in the incubator for the future would prove 
beneficial, since the device would remain stationary.  
 Testing cell proliferation and migration in each gradient device more times and for longer 
than 48 hours could enable more growth and movement to be seen. More data would allow for 
more statistically significant conclusions.  
 Future groups can use the devices produced to observe different cell lines and can flow 
different gases or fluids through, to observe those effects on cell proliferation, migration, and 
viability.  
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Appendix A- Cell Culturing 
Passaging Protocol 
1. Observe cells under microscope to determine confluency (75-80%) 
2. Aspirate media in plate 
3. Add 5mL of DPBS(-) with serological pipette and then aspirate DPBS (-) after rinsing the 
cells 
4. Add 3mL of 0.25% Trypsin-EDTA  
5. Place on the heating plate at 37°C for 10 minutes (observe under microscope to see cell 
detachment) 
6. Add 2mL of complete media to neutralize Trypsin 
7. Suspend the 5mL in a 15mL conical tube 
8. Remove 1mL for cell counting 
9. Centrifuge the 15mL conical tube at 200g for five minutes 
10. After centrifuge aspirate without disturbing the cells 
11. Add 1mL of cells onto a sterile culture dish and add 10mL of fresh media 
12. Observe cells under microscope and place in incubator to culture 
Passaging Table of Cultured Plates 
 The team started out culturing one plate. For B-term break the cells were frozen and four 
plates were replated.  
Passage Tables: 
1 Plate 
Date Passage Number Cells/mL 
November 3, 2016 0 500,000 
November 7, 2016 1 2,250,000 
November 11, 2016 2 2,750,000 
November 16, 2016 3 2,412,500 
November 21, 2016 4 2,807,000 
November 27, 2016 5 2,682,500 
November 30, 2016 6 1,732,500 
December 3, 2016 7 1,465,000 
December 6, 2016 8 1,250,000 
December 10, 2016 9 1,277,500 
December 12, 2016 (Freeze Cells) 10 500,000 
 
4 Plates 
Date Passage Number 1-1 (Cells/mL) 1-2  (Cells/mL) 2-1   (Cells/mL) 2-2   (Cells/mL) 
January 17, 2017 11 680,000 780,000 1,020,000 780,000 
January 21, 2017 12 1,397,500 1,412,500 935,000 1,216,000 
January 25,2017 13 1,545,000 1,362,500  1,945,000 
January 28, 2017 13   2,722,500  
January 29, 2017 14 1,670,000 2,642,500  2,110,000 
January 31, 2017 14   1,720,000  
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February 1, 2017 15 1,832,500 2,075,000 2,000,000 1,965,000 
February 4, 2017 16 1,110,000 1,690,000 2,310,000 1,940,000 
February 8, 2017 17 2,162,500 2,322,500, 2,570,000 2,495,000 
February 11, 2017 18   1,517,500  
February 12, 2017 18 2,190,000 2,380,000  2,117,500 
February 19, 2017 19   1,905,000 897,500 
February 22, 2017 19 2,470,500 2,990,000   
February 25, 2017 20   3,050,000 2,950,000 
February 27,2017 20 1,797,500    
February 28, 2017 20  2,482,000   
March 1, 2017 21 2,030,000 1,575,000 2,260,000 2,577,500 
March 12, 2017 22 2,006,000 2,312,500 2,000,000 2,452,000 
March 17, 2017 23 2,495,000 2,757,000   
March 20, 2017 23   2,065,000 2,177,500 
March 22, 2017 24 1,942,000 2,600,000   
March 25, 2017 24   2,025,000 2,332,500 
March 27, 2017 25 2,565,000 2,560,000   
March 30, 2017 25   2,440,000 2,052,500 
April 1, 2017 26 3,110,000 3,132,500   
April 3, 2017 26   1,542,500 1,992,500 
April 5, 2017 27 2,255,000 2,102,500   
April 8, 2017 27   1,140,000 1,457,500 
April 11, 2017 28 2,680,000 2,447,500   
 
Media Protocol for 50mL of 10% FBS Media 
1. Add 44mL of DMEM in a sterile 50mL conical tube 
2. Add 0.5mL of Glutamine  
3. Add 0.5mL of PennStrep 
4. Add 5mL of Fetal Bovine Serum 
5. Mix by gently inverting the 50mL conical tube multiple times 
6. Store in refrigerator when not in use 
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Appendix B- Cleaning the Microfluidic Device After Use 
Cleaning Protocol for Microfluidic Device After Experiment 
1. Place device in hood and place the cover slide in a new petri dish 
2. Aspirate any remaining media inside the well 
3. Remove well from device and place with cover slide 
4. Remove the hydrogel from device using a pipette tip (1000µL) into another clean petri 
dish 
5. Place device with well and cover slide 
6. Pour 5mL of isopropyl alcohol onto the device. Make sure to release all over the device 
7. Pour 2mL of isopropyl alcohol onto the cover slide and well, similar to the device. Let 
them submerged for five minutes 
8. Dry all components with a paper towel and place in a new petri dish 
9. Pour 5mL of ethanol on all components in the new petri dish and let them submerged for 
five minutes 
10. Dry all components using a paper towel and place them in a new petri dish for storage 
11. If device will be used the same day, place the petri dish with all components under UV 
Sterilization oven for two hours to sterilize. If it would not  be used the same day, 
sterilize the same way on the day of usage. 
12. Aspirate the petri dishes with isopropyl alcohol and ethanol 
13. Dispose of all petri dishes in the biohazard waste 
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Appendix C- COMSOL Simulations 
The following are models on COMSOL. Using the hydrogel, membrane and chambers to 
model the oxygen gradient. 
Parameters: 
• Hydrogel Dimensions: 27mm X 1.7mm(Thickness) 
• Membrane Dimensions: 25mm X 0.0635mm(Thickness) 
• No flux boundary all around the system 
• Diffusivity of Oxygen: 3.25*10-9[m2/s] 
• 1.97 x 10-9 [m2/s] (Ferrell & Himmelblau, 1967) 
o Simulates diffusion of oxygen in the hydrogel 
• Three Chambers: 5mm X 0.1mm each 
• 100µm gap between chambers 
• 21% oxygen in one chamber 
0% oxygen in one chamber 
• Line plots were taken at 200µm above the membrane 
• The bottom of the device was not used for modeling because it was presumed that it 
would not affect the oxygen gradient modeled. As can be seen below, analysis of the 
slope of the gradient was equal when comparing the models of the system with and 
without the bottom of the device. 
 
Complete Device 
 
 
Sharp Gradient in Complete Device 
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Shallow Gradient in Complete Device 
 
 
Full Device Compared to Displayed Models 
Sharp Gradient of Full Model compared to sharp gradient of displayed model of paper 
 
Overlay: 
 
As can be seen, the gradient slopes are equal. 
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Shallow Gradient of Full Model compared to shallow gradient of displayed model of paper 
 
 
 
As can be seen, the gradient slopes are equal. 
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Open Top Vs Closed Top 
Closed Top 
 
The max slope of the oxygen gradient is: 3.38 %O2/mm. 
 
Opened Top 
 
The max slope of the oxygen gradient is: 6.5 %O2/mm 
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Distance Between Chambers 
100µm  
 
The max slope of the oxygen gradient is: 25 %O2/mm 
 700µm 
 
The max slope of the oxygen gradient is: 14 %O2/mm 
 1mm 
 
The average max slope of the oxygen gradient is: 7.20 %O2/mm 
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Width of Chambers 
3mm 
 
The max slope of the oxygen gradient is: 4.75 %O2/mm 
 
5mm 
 
The max slope of the oxygen gradient is: 3.16 %O2/mm 
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Two Chamber Device Vs Three Chamber Device 
Two Chambers 
 
The max slope of the oxygen gradient is: 25.0 %O2/mm 
 
Three Chambers 
 
The max slope of the oxygen gradient is: 3.16 %O2mm 
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Membrane Height 
63µm 
 
The max slope of the oxygen gradient is: 25.0 %O2/mm 
 
250µm 
 
The average max slope of the oxygen gradient is: 7.00 %O2/mm 
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500µm 
 
The average max slope of the oxygen gradient is: 4.8 %O2/mm 
 
1mm 
 
The average max slope of the oxygen gradient is: 3.33 %O2/mm 
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Hydrogel Height (Sharp) 
500µm 
 
The average max slope of the oxygen gradient is: 9.75 %O2/mm 
 1mm 
 
The average max slope of the oxygen gradient is: 9.5 %O2/mm 
2mm 
 
The average max slope of the oxygen gradient is: 9.0 %O2/mm 
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3mm  
 
The average max slope of the oxygen gradient is: 8.75 %O2/mm 
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Gradients 
Sharp Gradient (100µm) 
 
The max slope of the oxygen gradient is: 25 %O2/mm 
 Intermediate Gradient (700µm) 
 
The max slope of the oxygen gradient is: 14 %O2mm 
 Shallow Gradient (5mm) 
 
The max slope of the oxygen gradient is: 3.1 %O2/mm 
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Appendix D- Financials 
Complete Item Price Table: 
Item Price 
MDA-MB-231/GFP/Blasticidin $395.00 (Gifted) 
Cell Culture Dishes $1.74 each (SL219) 
Pasteur Pipets $0.20 each (SL219) 
Serological Pipets (5mL) $0.21 each (SL219) 
Serological Pipets (10mL) $0.71 each (SL219) 
Serological Pipets (25mL) $0.67 each (SL219) 
Compressed Air Tank, Nitrogen Gas Tank and Carbon 
Dioxide Gas Tank 
$111.00 in Total (Purchased) 
Dulbecco’s Modified Eagle Medium (DMEM) (500mL) $33.23  (SL219) 
L-Glutamine (200mM) (100mL) $25.21  (SL219) 
Trypsin-EDTA (0.25%) (100mL) $12.52  (SL219) 
Penicillin-Streptomycin (100x) (100mL) $29.10  (SL219) 
Fetal Bovine Serum (100mL) $165.00 (SL219) 
Tygon Tubing 1/4in (6.35mm) $6 each Foot (30.2cm) 
(Borrowed) 
Pin $0.10 each (Borrowed) 
Needle $0.31 each (Borrowed) 
Sylgard 184 Silicone KIT (0.5kg) $60 each (Borrowed) 
PureCol EZ (35mL) $355.00 (SL219) 
Pipette Tip (10µL) $1.00 each (SL219) 
Pipette Tip (200µL) $1.00 each (SL219) 
Pipette Tip (1000µL) $1.00 each (SL219) 
Master Fabrication $360.00 (Gifted) 
Plasma Cleaner $1,234.00 (SL219) 
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Oven $214.00 (SL219) 
PDMS Hole Puncher (Biopsy Punch) $8.00 (Borrowed) 
Incubator $11,150.00 (SL219) 
Ultraviolet Sterilization Oven $75.00 (SL219) 
OceanOptics Ruthenium Coated Fluorescent Slide $275.00 (Borrowed) 
 
Gifted Items Table (no charge): 
Item Price 
MDA-MB-231/GFP/Blasticidin $395.00 
Master Fabrication $350.00 
The team received the MDA-MB-231/GFP/Blasticidin cells from Professor Ambady as a 
gift. The team was gifted a new master mold with the alternative designs from the 
microfabrication lab and BME595T at Worcester Polytechnic Institute.  
 
Borrowed Items Table: 
Item Price 
Tygon Tubing 1/4in (6.35mm) $6 each Foot (30.2cm) 
Pin $0.10 each 
Needle $0.31 each 
Sylgard 184 Silicone KIT (0.5kg) $60 each 
PDMS Hole Puncher (Biopsy Punch) $8.00 
Ocean Optics FOXY Ruthenium Coated Fluorescent Slide $275.00 
These items were borrowed from advisor Albrecht’s lab and from Elyse Favreau. Any 
leftovers were returned.  
 
Salisbury Lab 219 Table: 
The lab cost was $200 in total ($100 per student) and we were able to use the following items. 
Item Price 
Cell Culture Dishes $1.74 each 
Pasteur Pipets $0.20 each 
Serological Pipets (5mL) $0.21 each 
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Serological Pipets (10mL) $0.71 each 
Serological Pipets (25mL) $0.67 each 
Dulbecco’s Modified Eagle Medium (DMEM) (500mL) $33.23 
L-Glutamine (200mM) (100mL) $25.21 
Trypsin-EDTA (0.25%) (100mL) $12.52 
Penicillin-Streptomycin (100x) (100mL) $29.10 
Fetal Bovine Serum (100mL) $165.00 
PureCol Ez (35mL) $355.00 
Pipette Tip (10µL) $1.00 each 
Pipette Tip (200µL) $1.00 each 
Pipette Tip (1000µL) $1.00 each 
Plasma Cleaner $1,234.00 
Oven $214.00 
Incubator $11,150.00 
Ultraviolet Sterilization Oven $75.00 
 
Began with a budget of $500. After purchases totaling $311, a budget of  $189 remained.  
 
Estimated Prices 
The price to manufacture our device is about: $22.This includes the PDMS device, PDMS well, 
PDMS membrane and hole puncher. 
 
Experiment price each: $39.71.This includes device fabrication, cells, hydrogel, media, 2 pipette 
tips, and 1 serological pipette. 
Experiment with gas flow: $46.53. This includes device fabrication, cells, hydrogel, media, 2 
pipette tips, 1 serological pipette, 2 Tygon tubing, 2 needles, 2 pins and 2 luer locks. 
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Appendix E- Standard Operating Procedure For Creating 
and Observing Human Breast Cancer Migration in 
Microfluidic Device 
1.0 Purpose 
To describe the procedure to properly set-up an oxygen gradient experiment on the device and 
ensure safety. 
 
2.0 Scope 
This procedure applies to any personnel that wants to do an oxygen gradient experiment on the 
device. 
 
3.0 Responsibility 
All personnel that utilizes the device to observe cell proliferation and migration within an oxygen 
gradient. 
 
4.0 Definitions 
 
PDMS- Polydimethylsiloxane 
UV- Ultraviolet 
FBS- Fetal Bovine Serum (a component of complete media) 
FIJI- Fiji is just imageJ (image analysis program) 
5.0 Materials 
Device 
PDMS Membrane 
(2) Slide 
PDMS Well 
Petri Dish (60mm) 
Petri Dish (120mm) 
MDA-MB-231/GFP/Blasticidin (Breast Cancer Cells) 
Pipettor  
Pipette tip (200µL) 
Pipette tip (1mL) 
10% FBS Complete Media 
1 mL of PureCol EZ 
Incubator set to 37 degrees Celsius 
Fluorescent microscope  
(2) Pins 
(2) 1m long Tygon Tubing with a diameter of 6.35mm 
(2) 15.24cm long tubing with a diameter of 1mm 
(2) Needle 
(2) Luer lock 
Compressed air tank 
Nitrogen gas tank 
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Ultraviolet sterilization oven 
Ethanol 
Isopropyl alcohol 
Fluoride slide 
 
6.0 Procedure 
 
1. Clean the plasma bonded device with isopropyl alcohol and ethanol.  
2. Blow air onto the device to clear the dust. 
3. Ensure all dust is removed by placing tape on the device and peeling it off. 
4. Plasma bond the bottom of the device to a glass cover slide. 
5. Plasma bond a membrane, particularly one that is around 63.5µm in thickness to the top 
of the device. Make sure this is clean and free of dust by using ethanol and tape. Add a 
drop of ethanol to the fluorinated slide under the membrane to allow for easy removal. 
6. Place the plasma bonded device, well, and glass cover slide inside a 60mm petri dish and 
sterilize by putting them in a UV sterilization oven for at least 60 minutes. Ensure that the 
the UV light is hitting the components on all sides. 
7. While the device is being sterilized, attach one Tygon Tubing to the compressed air tank 
regulator. Attach a luer lock that has a needle attached to the other end of the Tygon 
Tubing. Attached to the needle is a small tubing with a diameter of 1mm. Attached to the 
1mm diameter tubing is a pin that will be inserted into the inlet of the device.  
8. Attach one Tygon Tubing to the nitrogen gas tank regulator. Attached to the other end of 
the Tygon Tubing is a luer lock that has a needle attached. Attached to the needle is a 
small tubing with a diameter of 1mm. Attached to the 1mm diameter tubing is a pin that 
will be inserted into a different inlet of the device. 
9. Turn the gases in each tank on. The pressure reading should be approximately 14kPa. 
10. To make sure that the flows are the same, put the pins of each needle in a beaker of 
water. The flows should look the same. 
11. The gases can be turned off for now.  
12. Passage the MDA-MB-231/GFP/Blasticidin cells following the passaging protocol in 
Appendix A and calculate the volume needed for 200,000 cells. 
13. After resuspending the cells from passaging, make sure to plate 1,000,000 cells. 
14. Remove the plasma bonded device and components from the UV sterilization oven. 
Make sure the petri dish is closed and bring into the hood. 
15. Get PureCol EZ from the refrigerator and make sure to keep it on ice 
16. Place the well properly on the device such that the channels are visible, but the inlets and 
outlet are covered. 
17. Add 0.5mL of PureCol EZ to the device. 
18. Ensure uniform distribution of the gel throughout the bottom of the well/top of the device 
by moving it around; the gel will slowly move. Make sure it covers the entire system. 
19. Add the calculated amount of µl to the PureCol EZ. Do this slowly and add drops 
throughout the top of the gel. Tilt the device around to more uniformly distribute the 
cells. 
20. Add the remaining 0.5mL of PureCol EZ inside the well. 
21. Allow at least 1 hour for the gel to solidify by placing the device in a petri dish into an 
incubator at 37 degrees Celsius. 
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22. After the gel has solidified, take images of the reference points and cells at various 
locations within the device. The reference point should be taken in brightfield, and the 
cells should be taken under the blue fluorescence (since they fluoresce green). Do not 
move the device when shifting to take images of the reference point and cells. They need 
to remain stationary to properly observe the migration and proliferation. The images 
taken typically include the top and bottom reference points (middle of the device), and 
the inlets and outlets. To properly observe migration, make sure that the microscope is 
focused on part of the device that can see the nitrogen chamber, the compressed air 
chamber, and the gradient in between. Make sure the reference point images are straight 
and even. 
23. When saving, make sure the images are saved as ome-tiffs and that there are scale bars on 
the images.  
24. Add 1mL of 10% FBS complete media to the well.  
25. Place the glass cover slide on top of the well.  
26. Put the device into a 120mm petri dish. 
27. Put the two tubings from the gas tanks into the back of the incubator. Add a stopper to 
ensure that the temperature and carbon dioxide from the incubator do not escape. 
28. Sterilize the pins that will be inserted into the device with alcohol. 
29. Put the device into the incubator and insert the gases into the appropriate inlets 
1. For a sharp gradient put the gases into the adjacent chamber inlets 
2. For a shallow gradient put the gases into opposite chamber inlets 
30. Note which inlet contains the nitrogen gas and which contains the compressed air. This 
will be important for the analysis. 
31. To be sure that the gases are flowing through the device a pin connected to a beaker of 
water can be used. Bubbling will ensure that the gases are flowing. 
32. After 24 hours image the same exact locations as the prior day and save. If needed add 
media to the device. 
33. Put the device back into the incubator and attach the tubing into the appropriate inlets. 
34. After 48 hours image the same exact locations again. 
35. If satisfied with the results, the device can be cleaned following the protocol in Appendix 
A. 
36. The images taken will be compared using the FIJI image analysis program to observe for 
cell proliferation and cell migration. 
1. Fluorescent images of cells at each time point (0, 24, 48 hours) are used 
for observing cell proliferation 
1. Load the image into FIJI 
2. Go to image → type → 16-bit 
3. Go to image → adjust → threshold (adjust it so that all the 
cells are red and the background is black). Click apply. 
4. Go to process → binary → watershed 
5. Count the particles by clicking analyze → analyze particles 
2. To observe migration load in the black and white reference point image 
and the focused fluorescent image of the cells at that point 
1. Overlay these two images through image → overlay → add 
image 
2. This will be done at each time point 
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3. The 0 and 48 hour image are compared using the line and measure 
tool 
1. Set the scale to 0.53 pixels = 1 micrometer 
4. Measure particular cells to the same location on reference point of 
both images 
5. Record the distance and which way the cell migrated 
 
7.0 Attachments 
1.) Passage protocol (Appendix A) 
1. Observe cells under microscope to determine confluency (75-80%) 
2. Aspirate media in plate 
3. Add 5mL of DPBS(-) with serological pipette and then aspirate DPBS (-) after rinsing the 
cells 
4. Add 3mL of 0.25% Trypsin-EDTA  
5. Place on the heating plate at 37°C for 10 minutes (observe under microscope to see cell 
detachment) 
6. Add 2mL of complete media to neutralize Trypsin 
7. Suspend the 5mL in a 15mL conical tube 
8. Remove 1mL for cell counting 
9. Centrifuge the 15mL conical tube at 200g for five minutes 
10. After centrifuge aspirate without disturbing the cells 
11. Add 1mL of cells onto a sterile culture dish and add 10mL of fresh media 
12. Observe cells under microscope and place in incubator to culture 
2.) 10% FBS media production protocol (Appendix A) 
 
Media Protocol for 50mL of 10% FBS Media 
1. Add 44mL of DMEM in a sterile 50mL conical tube 
2. Add 0.5mL of Glutamine  
3. Add 0.5mL of PennStrep 
4. Add 5mL of Fetal Bovine Serum 
5. Mix by gently inverting the 50mL conical tube multiple times 
6. Store in refrigerator when not in use 
 
 
 
 
 
 
 
 
 
 
 
